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This toxicological research was conducted to aid in the development of a multicriteria decision-
making tool to facilitate selection of functional yet greener and safer metalworking fluids 
(MWF). This research also satisfies a long-felt need of workers to understand the health risks 
associated with MWF and a desire to minimize such risks. Utilization of such a tool is expected 
to lead to improved MWF purchasing decisions through (i) data dependent decision making 
transparency, (ii) specific articulation and acknowledgment of the multiple criteria often 
involved in such choice, and (iii) built-in flexibility to reflect and incorporate site-specific 
preferences and constraints. The specific objectives of this project were: (i) identification of the 
key characteristics of MWFs that contribute to their utility, economics, environmental, and 
health and safety aspects; (ii) identification and evaluation of appropriate measures for the above 
characteristics; (iii) choice and evaluation of an appropriate decision making model to analyze 
and synthesize the above information; and (iv) development of a user-friendly format to present 
the end-results of such an analysis. We also intended to develop and test a transiently stable 
emulsion mixture for providing machining functionality, ease of maintenance, and a superior 
safety profile. Toxicity data collected on MWF components collected both through a literature 
search and through testing can guide the choice of components for developing the transiently 
stable emulsion. 
 
Twelve MWFs and 10 MWF components were evaluated for their chronic cytotoxicity using an 
in vitro CHO cell bioassay. For both the MWFs and the MWF components, the range of 
cytotoxicity was within standard toxic agents regulated by the U.S. Environmental Protection 
Agency. For the MWF classes there was an overall descending cytotoxicity rank order of MWFs 
of semi-synthetic, followed by soluble oil, followed by synthetic. For these MWF classes, the 
CHO cell cytotoxicity assay was highly correlated with in vivo pulmonary toxicity measurements 
in animal models. Our results indicate that for both the MWF and MWF components, a wide 
diversity of cytotoxicity is present. Our data may be used to select MWFs or MWF components 
that meet industry requirements and pose the lowest level of toxic hazard. 
 
• The MWF rank order, from most cytotoxic to least cytotoxic, was Castrol 6510 > Castrol 
Clearedge 6536 > Alusol AU39 > Cimperial 1070 > Vita Edge > Castrol 6519 > TrimSol 
> TrimE 206nd > Eaton Hocut 763 > Hangsterfer’s S506 > Syntilo 9904 > IRMCO  
Cutting Fluid Product A.  
 
• The MWF component rank order, from most cytotoxic to least cytotoxic, was Atramide 
202 > Alkaterg T-IV > Busan 77 > Mayfree 133 > Dover Maylube 112 > AMP95 > 





We have developed a multicriteria decision-making tool to facilitate selection of functional yet 
greener metalworking fluids by reducing the environmental and health and safety footprint of 
metalworking fluids (MWFs). This research satisfies a long-felt need of workers to understand 
the health risks associated with MWF, and a desire to minimize such risks by appropriate 
choices. Utilization of such a tool is expected to lead to (i) improved MWF purchasing decisions 
through data dependent decision making transparency, (ii) through specific articulation and 
acknowledgment of the multiple criteria often involved in such a choice, and (iii) built-in 
flexibility to reflect and incorporate site-specific preferences and constraints. The specific 
objectives of this project were: (i) identification of the key characteristics of the MWF that 
contribute to its utility, economics, and environmental and health and safety aspects, (ii) 
identification and evaluation of appropriate measures for the above characteristics, (iii) choice 
and evaluation of an appropriate decision making model to analyze and synthesize the above 
information, and, (iv) development of a user friendly format to present the end-results of such an 
analysis. 
 
In addition to the above objectives, the project intended to develop and test a transiently stable 
emulsion mixture for providing machining functionality, ease of maintenance, and a superior 
safety profile. Toxicity data collected on MWF components collected both through a literature 
search and through testing will guide the choice of components for developing the transiently 
stable emulsion. 
Background 
The higher machining rates and productivity gains achieved throughout the machine-tool 
industry during the past few decades have resulted in large part from the improved formulation 
and application of metalworking fluids (MWF). The trend towards higher velocity machining 
will place even greater demands on MWF [1]. However, the use of MWF is a double-edged 
sword and brings with it a host of problems. Three key issues associated with the use and 
disposal of metalworking fluids are: (i) economic, (ii) environmental, and (iii) health and safety. 
Economic Issues 
MWF are reported to contribute as much as 8 to 16% of machining costs [2], including the cost 
of the MWF, maintenance, energy use, disposal, and equipment related costs. Many of these 
costs can be avoided by improving process efficiency, developing and instituting appropriate 
monitoring and control strategies, and holistic system design. The economics of MWF disposal 
reveal that the value of raw materials lost in the waste due to disposal can vary from $200 to 




 Environmental Concerns 
It is estimated that the total volume of MWF being disposed annually is at least 2 billion gallons 
in the U.S., spread across thousands of small facilities. MWF are typically high in oil content, 
surfactants, chelates, and biocides [3]. The resulting effluent stream imposes a significant stress 
on the nation’s water treatment plants and waterways. Typical disposal is often into POTW 
where they create problems such as high BOD loading. The MWF additives create additional 
wastewater treatment problems such as lowering the efficacy of heavy metals precipitation and 
increasing emulsification of oil and foaming [4]. The quality of effluent streams produced by 
widely used waste treatment options such as chemical treatment or ultrafiltration vary widely [5, 
6].  
Health and Safety Impacts 
Significant concerns exist as to the adverse health effects on machinists and workers associated 
with MWF. The primary adverse health effects due to MWF exposure are (i) bacterial-mediated 
respiratory disease, (ii) dermal and systematic toxicity, and (iii) the induction of cancer.  The 
isolation of pathogenic or potentially pathogenic organisms such as Pseudomonas aeruginosa, 
Staphylococcus aureus, Escherichia coli, and Legionella from MWF raise issues of worker 
safety. One notable example of disease related to MWF is an outbreak of Pontiac fever in an 
engine manufacturing plant due to Legionella [7]. It has also been established quite clearly that 
large quantities of antigenic bacterial components are present in MWF aerosols [8, 9]. One 
important example of antigenic material in MWF is endotoxin, a large molecular weight lipo-
polysaccharide-protein complex that is released on microbial lysis or microbial cell wall 
destruction, usually a mode of action of the biocide additives. Several studies have established 
direct correlations between respiratory illnesses and endotoxin exposure [10-12]. MWF-mediated 
dermal and systematic toxicity is a serious and constant issue in occupational health [13-15]. 
Several studies have associated MWF occupational exposure and the induction of various 
cancers including cancer of the larynx, rectum, pancreas, skin, scrotum, and bladder [9, 16-18]. 
Recent studies have focused attention on the induction of MWF-associated cancer of the colon-
rectum [19], prostrate [16] and breast [20]. However, until the present study, no systematic 







For this project we conducted a mammalian cell chronic cytotoxicity analysis of MWFs or MWF 




Table 1. General characteristics of metalworking fluids and metalworking fluid components analyzed in this 
study. 
 
Metalworking Fluid Type Common Use 
Castrol Clearedge 6510 Semi-Synthetic Ferrous Metals 
Castrol Clearedge 6519 Semi-Synthetic Ferrous or Non-Ferrous Metals 
Cimperial-1070 Soluble Oil Ferrous or Non-Ferrous Metals 
Eaton Hocut 763 Synthetic Steel 
Hangsterfer’s S-506 Soluble Oil Aluminum, Stainless Steel, Titanium 
Syntilo 9904 Synthetic Ferrous Metals 
TrimE 20bnd  Soluble Oil Ferrous or Non-Ferrous Metals 
Trim Sol Soluble Oil General Purpose, Ferrous or Non-Ferrous Metals 
Vita Edge Soluble Plant Oil General Purpose 
Alusol AU39 Semi-Synthetic Automotive Aluminum Alloys 
Castrol Clearedge 6536 Semi-Synthetic Grinding Operations 
IRMCO Cutting Fluid Product A Synthetic General Purpose 
Busan 77 − MWF component  
UCON EMPL-48 − MWF component 
AMP95 − MWF component 
UCON 50-HB-6 − MWF component 
Alkaterg T-IV − MWF component 
Actramide 202 − MWF component 
Dover Mayfree 133 − MWF component 
Dover Sulperm HO − MWF component 
Dover Maylube 112 − MWF component 






 Biological Assays 
Maintenance of CHO Cells 
 
Stock cultures of Chinese hamster ovary (CHO) line AS52, clone 11-4-8 cells were frozen in a 
solution of 90% fetal bovine serum (FBS):10% dimethylsulfoxide (DMSO) (v/v) and stored at 
−80°C. Cells were grown on glass culture plates in Hams F12 medium plus 5% FBS at 37°C in a 
humidified atmosphere of 5% CO2. The cells exhibit normal morphology, express cell contact 
inhibition and grow as a monolayer without expression of neoplastic foci. CHO cells were 








Figure 1. A microphotograph of CHO cells from line AS52, clone 11-4-8. CHO cells are widely used in toxicology 
research. These cells express functional p53 protein and are competent for DNA repair. The cells exhibit normal 







 Solubility of MWF or MWF Components 
 
Using a biological assay demands that the test agents be soluble or be emulsified in an aqueous 
solution for presentation to the CHO cells. Most of the MWF agents were soluble or formed an 
emulsion with water; however, several of the MWF components had solubility difficulties. These 
are the agents that are being incorporated into the on-site combination of MWF components. To 
dissolve some of these materials, we used a 50% solution of water and dimethylsulfoxide 
(DMSO) and an ultrasonic probe to disperse the agent into a solution. For the more difficult 
MWF components, we used a number of emulsifiers and emulsifiers plus DMSO solutions for 
increasing the solubility of the MWF components. The use of emulsifiers proved to be 
unacceptable because they dissolved the cell membranes. We finally found that a 1:1 (v/v) 
mixture of DMSO:ethanol allowed the suspension of the Dover MWF components. The initial 
Dover MWF components were then diluted serially in F12 medium with FBS for use with the 
CHO cell chronic cytotoxicity assay. All experiments were conducted at concentrations of the 
solvent carrier that was below 0.5% which was not toxic to the CHO cells. 
CHO Cell Chronic Cytotoxicity Assay 
 
This assay measured the reduction in cell density as based on crystal violet staining as a function 
of MWF concentration, over a period of approximately 3 cell divisions (72 h) (Figure 2) [23]. 
This assay has been used to quantitatively compare the levels of mammalian cell cytotoxicity 
induced by drinking water disinfection by-products [23-32], pesticides [33-36], and medical 
agents [37], and is being used to study complex mixtures isolated from environmental samples 
[38]. The data were automatically recorded and transferred to an Excel spreadsheet in a 
microcomputer connected to the microplate reader. The blank-corrected absorbency value of the 
negative control (cells with medium only) was set at 100%. The absorbency for each treatment 
group well was converted into a percentage of the negative control. In general for each MWF 
sample, approximately 10 concentrations with 8 replicate wells were analyzed per experiment 
and the experiments were repeated two to three times (Figure 3). 
 
From the summary data, we plotted a cytotoxicity concentration-response curve for each MWF 
analyzed. The data were curve fitted and regression analysis was conducted. The coefficient of 
determination (R2) was determined and the %C½ value for each concentration-response curve 
was calculated. The %C½ value (analogous to a LC50 value) is the concentration of the test 
agent, determined from a regression analysis of the data that induced a cell density of 50% as 
compared to the concurrent negative control. The data from the cytotoxicity experiments were 
transferred to Excel spreadsheets and analyzed using the statistical and graphical functions of 
SigmaPlot 8.02, SigmaStat 3.1, and Table Curve 4.03. The crystal violet absorbancy data 
collected by the Bio-Rad microplate reader was saved as a text file (.txt) with the experiment 
number and transferred to an Excel spreadsheet. The original absorbancy data, the blank-
corrected, and the conversion to the percent of the negative control values were saved on the 
spreadsheet for each MWF analyzed. For each MWF, a summary page was prepared and all of 
the statistical data was conducted on the percent of the negative control values. A concentration-
response cytotoxicity curve for each MWF was generated from the summary page and a one-way 
analysis of variance (ANOVA) test was conducted to determine if the MWF induced a significant 
level of cell killing at a specific concentration. If a significant F value of P ≤ 0.05 was obtained, 
5 
 
 a Holm-Sidak multiple comparison versus the control group analysis was conducted. The power 
























Figure 2. Calibration of the CHO cell cytotoxicity assay. (A) Absorption spectrum of crystal violet in the range 
from 340–800 nm. The maximum absorbancy of crystal violet was between 585–595 nm. (B) A comparison of the 
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Figure 3. A stained microplate illustrating the CHO cell chronic cytotoxicity assay. The control (column 1) 
contained cells not exposed to the test MWF agent (negative control). The blank column without cells was used to 
determine the absorbancy of the crystal violet histological dye that was not associated with cells and to normalize 
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 RESULTS  
 
The results of the experiments preformed on the metalworking fluids and MWF components 
listed in Table 1 are presented in the following tables and figures. 
Metalworking Fluids 
Castrol Clearedge 6510 
 
The summary data for the CHO cell cytotoxicity assay for Castrol 6510 is presented in Table 2 
and the statistical analysis is presented in Table 3. Figure 4 presents the cytotoxicity 




Table 2. Summary of CHO cell cytotoxicity of Castrol 6510.  




0 5 10 15 20 25 30 35 40
125.69 88.35 97.56 53.66 60.43 98.92 74.53 33.33 -19.24
103.40 108.67 86.18 77.78 76.96 105.42 66.94 60.98 -28.18
97.03 116.53 104.07 60.98 120.33 100.81 72.36 60.70 19.24
102.76 112.47 94.31 102.71 127.37 86.72 56.10 29.00 18.43
85.56 114.36 106.78 89.16 118.43 117.89 83.47 31.71 21.95
94.69 121.41 92.14 99.19 94.31 60.16 73.44 28.18 24.93
103.40 128.18 123.85 131.44 139.02 80.76 59.62 24.39 29.00
87.90 67.48 98.64 95.66 108.13 37.67 37.67 -22.22 34.96
52.98 129.47 152.66 88.40 99.37 103.45 39.50 -6.58
83.70 120.69 98.75 79.62 99.69 88.09 32.60 -3.13
65.52 113.79 106.27 77.12 71.47 67.08 30.09 -25.39
105.02 97.81 96.87 104.70 53.61 78.37 57.37 -27.27
115.67 130.41 103.76 93.73 69.91 74.92 -1.57 -17.55
99.06 111.29 92.79 101.57 54.23 51.72 7.52 -22.57
145.14 130.72 105.33 105.64 58.93 66.14 46.08 5.02









24.00 24.00 16.00 16.00 16.00 24.00 16.00 8.00 16.00 number
100.02 100.85 105.69 89.85 86.94 63.67 45.96 30.76 -0.27 Average
4.19 4.64 4.23 4.74 7.61 5.93 6.76 9.14 5.55 SE
Experiment 031006A 033106A 040406A Castrol 6510 MWF CHO Cytotoxicity % NEGATIVE CONTROL SUMMARY
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 Table 3. Statistical analysis of the CHO cell cytotoxicity data of Castrol 6510.  
 
Data source: Data 7 in MWF 122706.SNB 
Group Name N Missing Mean Std Dev SEM 
6510 0 µg/mL 24 0 100.021 20.518 4.188 
6510 5 µg/mL 24 0 100.852 22.708 4.635 
6510 10 µg/mL 16 0 105.686 16.909 4.227 
6510 15 µg/mL 16 0 89.846 18.945 4.736 
6510 20 µg/mL 16 0 86.942 30.421 7.605 
6510 25 µg/mL 24 0 63.675 29.061 5.932 
6510 30 µg/mL 16 0 45.963 27.022 6.755 
6510 35 µg/mL 8 0 30.759 25.842 9.136 
6510 40 µg/mL 16 0 -0.265 22.190 5.547 
 
Source of Variation DF SS MS F P 
Between Groups 8 174655.959 21831.995 37.661 <0.001 
Residual 151 87533.363 579.691   
Total 159 262189.322    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





6510 0 µg/mL vs. 6510 40 µg/mL 100.287 12.906 3.755E-026 0.006 Yes 
6510 0 µg/mL vs. 6510 35 µg/mL 69.262 7.047 6.092E-011 0.007 Yes 
6510 0 µg/mL vs. 6510 30 µg/mL 54.058 6.957 9.887E-011 0.009 Yes 
6510 0 µg/mL vs. 6510 25 µg/mL 36.346 5.229 0.000000558 0.010 Yes 
6510 0 µg/mL vs. 6510 20 µg/mL 13.079 1.683 0.0944 0.013 No 
6510 0 µg/mL vs. 6510 15 µg/mL 10.176 1.309 0.192 0.017 No 
6510 0 µg/mL vs. 6510 10 µg/mL 5.665 0.729 0.467 0.025 No 














































Castrol 6510 Concentration (µg/ml)


















































 Castrol Clearedge 6519 
 
The summary data for the CHO cell cytotoxicity assay for Castrol 6519 is presented in Table 4 
and the statistical analysis is presented in Table 5. Figure 5 presents the cytotoxicity 




Table 4. Summary of CHO cell cytotoxicity of Castrol 6519.  







0 2.5 5 12.5 25 37.5 50 60 75 85 100 125 150 µg/ml
0 0.5 1 2.5 5 7.5 10 12 15 17 20 25 30 µg/well
105.56 91.11 76.22 78.44 82.00 86.75 61.56 51.62 61.10 19.24 6.00 13.77 8.61
91.33 77.11 66.22 68.44 61.33 80.03 39.78 23.92 57.14 10.89 5.85 4.48
87.33 73.33 70.22 66.00 58.89 71.94 44.44 48.74 65.40 24.82 26.00 12.74 1.89
91.33 93.78 75.56 70.22 60.67 77.28 43.33 28.06 48.71 28.60 13.78 8.43 3.79
109.56 86.89 76.89 71.11 62.89 71.94 40.22 50.72 58.86 19.11 15.49 6.54
93.78 79.56 74.22 66.89 50.67 69.71 40.89 46.22 57.14 16.19 13.78 15.66 2.24
110.22 88.89 76.67 74.89 64.67 81.07 51.33 70.50 24.10 25.56 13.94 9.12
110.00 106.00 68.44 82.89 68.67 67.30 44.00 35.07 13.31 22.00 12.22 3.96
109.12 127.37 97.59 55.58 79.00 23.38 39.76 -7.01 -10.07
117.21 114.97 78.14 60.07 66.27 34.35 33.22 -3.24
93.29 103.61 70.91 71.22 69.54 35.79 32.36 8.45 0.00
89.50 99.66 79.35 63.68 33.99 32.36 -9.35 -5.94
97.59 104.30 71.26 67.09 65.75 34.94 -8.99 -3.42
91.57 85.20 79.35 38.85 69.88 32.01 -8.99 -12.05
110.15 95.70 74.35 44.96 64.37 39.59 -16.19
91.05 86.75 72.98 66.95 39.76 1.98 10.07
104.14 101.62 75.36 70.86 10.07
78.06 90.11 48.20 57.37 20.68
105.22 62.95 73.74 57.91 21.94
94.06 71.76 71.58 34.17 2.70
87.95 71.94 59.35 24.28
95.68 50.00 44.78 53.42
111.69 69.60
123.38 52.34
24.00 8.00 22.00 8.00 22.00 14.00 24.00 7.00 12.00 5.00 20.00 14.00 16.00 number
99.95 87.08 84.11 72.36 68.49 67.41 55.46 45.68 44.59 20.43 23.82 5.30 -0.01 Average
2.28 3.70 3.99 2.10 2.61 3.63 2.85 5.92 4.35 2.79 2.59 2.64 1.96 SE
11.19 10.47 18.71 5.93 12.22 13.56 13.98 15.66 15.06 6.25 11.58 9.87 7.86 SD
Experiments 011105, 012505, 020105 Castrol 6519 MWF SUMMARY SHEET CHO Cytotoxicity % NEGATIVE CONTROL
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 Table 5. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Castrol 6519.  
 
Data source: Data 4 in MWF 073105.SNB 
Group Name  N  Missing Mean Std Dev SEM 
C6519 0 µg/mL 24 0 99.949 11.188 2.284 
C6519 2.5 µg/mL 8 0 87.083 10.470 3.702 
C6519 5 µg/ml 22 0 84.108 18.707 3.988 
C6519 12.5 µg/mL 8 0 72.361 5.930 2.096 
C6519 25 µg/mL 22 0 68.487 12.220 2.605 
C6519 37.5 µg/mL 15 1 67.414 13.564 3.625 
C6519 50 µg/mL 24 0 55.457 13.976 2.853 
C6519 60 µg/mL 7 0 45.683 15.655 5.917 
C6519 75 µg/mL 12 0 44.588 15.065 4.349 
C6519 85 µg/mL 8 3 20.432 6.247 2.794 
C6519 100 µg/mL 20 0 23.825 11.585 2.590 
C6519 125 µg/mL 16 2 5.299 9.872 2.638 
C6519 150 µg/mL 16 0 -0.0130 7.858 1.964 
 
Source of Variation DF SS MS F P 
Between Groups 12 194261.377 16188.448 98.330 <0.001 
Residual 183 30128.104 164.634   
Total 195 224389.481    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





C6519 0 µg/mL vs. C6519 150 µg/mL 99.962 24.138 8.982E-059 0.004 Yes 
C6519 0 µg/mL vs. C6519 125 µg/mL 94.650 21.935 4.135E-053 0.005 Yes 
C6519 0 µg/mL vs. C6519 100 µg/mL 76.124 19.595 8.248E-047 0.005 Yes 
C6519 0 µg/mL vs. C6519 85 µg/mL 79.517 12.606 1.241E-026 0.006 Yes 
C6519 0 µg/mL vs. C6519 75 µg/mL 55.361 12.204 1.906E-025 0.006 Yes 
C6519 0 µg/mL vs. C6519 50 µg/mL 44.492 12.012 6.969E-025 0.007 Yes 
C6519 0 µg/mL vs. C6519 60 µg/mL 54.265 9.845 1.273E-018 0.009 Yes 
C6519 0 µg/mL vs. C6519 25 µg/mL 31.462 8.307 2.137E-014 0.010 Yes 
C6519 0 µg/mL vs. C6519 37.5 µg/mL 32.535 7.540 2.114E-012 0.013 Yes 
C6519 0 µg/mL vs. C6519 12.5 µg/mL 27.588 5.267 0.000000387 0.017 Yes 
C6519 0 µg/mL vs. C6519 5 µg/mL 15.841 4.183 0.0000446 0.025 Yes 
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The summary data for the cytotoxicity assay for Cimperial-1070 is presented in Table 6 with the 




Table 6. Summary of CHO cell cytotoxicity of Cimperial-1070. 
 
   
0 2.5 5 12.5 25 30 35 40 45 50 60 70 75 90 100 125 µg/ml
0 0.5 1 2.5 5 6 7 8 9 10 12 14 15 18 20 25 µg/well
104.4 95.9 93.9 82.1 70.5 84.2 72.1 44.8 48.6 42.1 20.8 1.9 15.9 6.3 13.8 3.8
95.9 84.1 83.8 82.1 68.1 79.2 66.5 37.7 44.9 35.8 19.8 4.4 22.2 10.5 8.7 -2.5
88.6 78.2 89.3 87.8 77.3 80.2 74.0 52.7 51.3 33.6 24.7 5.4 23.4 17.2 10.5 -1.7
93.0 88.2 88.2 77.9 73.1 69.4 69.7 28.0 48.0 32.5 21.8 15.6 17.6 2.5 8.1 -2.5
101.1 86.5 87.1 84.5 81.2 71.3 62.2 31.0 47.8 40.4 21.0 17.9 17.2 12.1 9.0 -2.9
103.1 84.9 88.2 91.7 72.9 56.6 57.2 54.0 42.2 28.4 15.6 12.1 8.8 12.1 10.7 -3.8
114.2 87.6 91.9 91.9 79.7 53.9 46.2 47.7 53.4 39.7 25.8 19.3 22.2 8.8 14.8 0.8
100.2 97.6 89.1 107.4 102.0 36.2 35.6 56.5 28.5 31.0 11.9 18.7 14.2 6.7 2.6 -1.3
113.0 92.1 87.0 61.5 68.0 49.8 8.5 4.6
98.7 90.0 91.2 73.2 63.2 44.8 12.9 4.6
92.1 94.1 79.5 80.3 58.4 67.4 14.1 9.2
92.9 85.4 90.8 87.4 52.8 57.7 10.4 3.3
92.5 102.1 87.9 89.5 40.3 73.2 7.7 7.5
81.2 92.1 77.0 73.2 59.0 68.2 -0.6 -0.8
130.5 84.5 82.8 78.7 27.7 54.8 18.5 6.3
99.2 77.4 69.0 82.0 59.0 -4.4 2.1
131.8 70.3 30.3 8.3
102.7 76.5 36.2 6.7
91.1 85.2 30.8 -2.5
85.0 71.3 34.5 -3.9
94.8 67.6 29.9 -4.8
100.0 61.7 21.8 -5.4
108.7 39.9 28.9 0.6
86.3 22.0 -6.2
24 8 16 16 23 8 8 15 8 24 8 8 16 8 24 8 number
100.0 87.9 89.3 85.7 74.9 66.4 60.5 48.1 45.6 41.4 20.2 11.9 13.0 9.5 4.5 -1.3 Average
2.58 2.23 1.37 2.14 2.48 5.77 4.77 3.30 2.72 3.03 1.61 2.49 1.96 1.59 1.24 0.87 SE
12.63 6.30 5.46 8.57 11.91 16.31 13.48 12.78 7.70 14.83 4.54 7.05 7.82 4.49 6.05 2.45 SD
Experiments 011105JPMP, 030105JPMP, 030805JPMP  Cimperial 1070 MWF SUMMARY SHEET CHO Cytotoxicity % NEGATIVE CONTROL
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 Table 7. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Cimperial-1070.   
 
Data source: Data 5 in MWF 073105.SNB 
Group Name N Missing Mean Std Dev SEM 
CI1070 0µg/ml 24 0 100.034 12.625 2.577 
CI1070 2.5µg/ml 8 0 87.855 6.300 2.227 
CI1070 5µg/ml 16 0 89.322 5.461 1.365 
CI1070 12.5µg/ml 16 0 85.671 8.569 2.142 
CI1070 25µg/ml 23 0 74.925 11.910 2.483 
CI1070 30µg/ml 8 0 66.378 16.314 5.768 
CI1070 35µg/ml 8 0 60.453 13.478 4.765 
CI1070 40µg/ml 15 0 48.109 12.784 3.301 
CI1070 45µg/ml 8 0 45.568 7.704 2.724 
CI1070 50µg/ml 24 0 41.367 14.830 3.027 
CI1070 60µg/ml 8 0 20.183 4.541 1.605 
CI1070 70µg/ml 8 0 11.922 7.051 2.493 
CI1070 75µg/ml 16 0 13.030 7.822 1.956 
CI1070 90µg/ml 8 0 9.519 4.488 1.587 
CI1070 100µg/ml 24 0 4.494 6.055 1.236 
CI1070 125µg/ml 8 0 -1.255 2.450 0.866 
 
Source of Variation DF SS MS F P 
Between Groups 15 260054.241 17336.949 162.735 <0.001 
Residual 206 21946.173 106.535   
Total 221 282000.414    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





CI1070 0 µg/mL vs. CI1070 100 µg/mL 95.540 32.065 5.020E-082 0.003 Yes 
CI1070 0 µg/mL vs. CI1070 75 µg/mL 87.005 26.118 2.733E-067 0.004 Yes 
CI1070 0 µg/mL vs. CI1070 125 µg/mL 101.289 24.038 1.082E-061 0.004 Yes 
CI1070 0 µg/mL vs. CI1070 90 µg/mL 90.515 21.481 1.731E-054 0.004 Yes 
CI1070 0 µg/mL vs. CI1070 70 µg/mL 88.112 20.911 7.804E-053 0.005 Yes 
CI1070 0 µg/mL vs. CI1070 50 µg/mL 58.667 19.690 3.077E-049 0.005 Yes 
CI1070 0 µg/mL vs. CI1070 60 µg/mL  79.851 18.950 5.020E-047 0.006 Yes 
CI1070 0 µg/mL vs. CI1070 40 µg/mL 51.925 15.285 9.368E-036 0.006 Yes 
CI1070 0 µg/mL vs. CI1070 45 µg/mL 54.466 12.926 2.238E-028 0.007 Yes 
CI1070 0 µg/mL vs. CI1070 35 µg/mL 39.581 9.393 1.132E-017 0.009 Yes 
CI1070 0 µg/mL vs. CI1070 25 µg/mL 25.109 8.337 1.078E-014 0.010 Yes 
CI1070 0 µg/mL vs. CI1070 30 µg/mL 33.657 7.987 9.607E-014 0.013 Yes 
CI1070 0 µg/mL vs. CI1070 12.5 µg/mL 14.364 4.312 0.0000251 0.017 Yes 
CI1070 0 µg/mL vs. CI1070 5 µg/mL 10.713 3.216 0.00151 0.025 Yes 
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 Eaton Hocut 763 
 
The summary data for the CHO cell cytotoxicity assay for Eaton Hocut 763 is presented in Table 
8 and the statistical analysis is presented in Table 9. Figure 7 presents the cytotoxicity 




Table 8. Summary of CHO cell cytotoxicity of Eaton Hocut 763.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 25 50 75 100 125 150 175 200 µg/ml
0 5 10 15 20 25 30 35 40 µg/well
96.76 90.31 97.92 97.58 45.67 46.71 44.98 29.41 38.75
90.52 99.31 88.24 102.08 67.13 54.67 45.67 26.64 35.99
101.75 116.26 97.58 95.85 75.78 46.37 39.45 24.91 10.38
110.22 91.70 83.74 104.84 75.78 58.48 42.91 47.40 22.84
96.51 120.76 125.61 100.35 66.44 29.41 66.78 16.96 17.99
111.22 87.54 81.31 101.04 68.51 51.21 16.61 24.22 6.57
107.48 130.80 80.28 46.02 74.39 75.43 27.34 2.42 10.38
85.04 74.05 51.56 44.64 44.64 55.36 22.84 37.72 -14.88
79.24 78.65 76.99 73.34 35.84 24.23 9.73 -7.41 -16.70
107.61 78.87 69.14 53.65 48.78 28.54 12.83 -2.32 -7.63
125.95 74.78 55.09 64.93 57.74 25.66 20.13 3.87 -7.63
82.01 83.30 70.13 46.13 48.23 24.00 16.48 -3.65 -8.63
129.41 104.31 72.90 49.23 48.12 22.35 17.04 4.98 -10.29
85.12 95.35 65.38 51.11 51.22 19.14 18.36 1.00 -11.39
100.69 88.16 72.35 62.06 44.14 16.26 5.09 -0.66 -13.38









24 16 16 16 16 16 16 16 16 Number
100.04 93.13 78.94 71.83 55.25 37.52 25.31 12.26 2.26 Average
2.79 4.31 4.46 6.00 3.58 4.44 4.50 4.35 4.65 SE
13.68 17.23 17.85 23.99 14.32 17.76 17.98 17.41 18.59 SD







 Table 9. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Eaton Hocut 763. 
 
Data source: Data 8 in MWF 122706.SNB 
Group Name  N Missing Mean Std Dev SEM 
EH763 0 µg/mL 24 0 100.036 13.683 2.793 
EH763 25 µg/mL 16 0 93.134 17.235 4.309 
EH763 50 µg/mL 16 0 78.936 17.851 4.463 
EH763 75 µg/mL 16 0 71.828 23.987 5.997 
EH763 100 µg/mL 16 0 55.253 14.325 3.581 
EH763 125 µg/mL 16 0 37.517 17.763 4.441 
EH763 150 µg/mL 16 0 25.314 17.980 4.495 
EH763 175 µg/mL 16 0 12.255 17.408 4.352 
EH763 200 µg/mL 16 0 2.263 18.594 4.648 
 
Source of Variation DF SS MS F P 
Between Groups 8 178339.990 22292.499 71.533 <0.001 
Residual 143 44564.233 311.638   
Total 151 222904.223    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





EH763 0 µg/mL vs. EH763 200 µg/mL 97.773 17.160 1.534E-036 0.006 Yes 
EH763 0 µg/mL vs. EH763 175 µg/mL 87.781 15.407 3.516E-032 0.007 Yes 
EH763 0 µg/mL vs. EH763 150 µg/mL 74.722 13.115 2.692E-026 0.009 Yes 
EH763 0 µg/mL vs. EH763 125 µg/mL 62.519 10.973 1.052E-020 0.010 Yes 
EH763 0 µg/mL vs. EH763 100 µg/mL 44.783 7.860 8.441E-013 0.013 Yes 
EH763 0 µg/mL vs. EH763 75 µg/mL 28.208 4.951 0.00000205 0.017 Yes 
EH763 0 µg/mL vs. EH763 50 µg/mL 21.100 3.703 0.000303 0.025 Yes 











Eaton Hocut 763 (µg/ml)

















































 Hangsterfer’s S-506 
 
The summary data for the CHO cell cytotoxicity assay for Hangsterfer’s S-506 is presented in 
Table 10 and the statistical analysis is presented in Table 11. Figure 8 presents the cytotoxicity 




Table 10. Summary of CHO cell cytotoxicity of Hangsterfer’s S-506.  
0 5 35 50 60 75 85 100 120 125 140 150 160 200 225 250 300 µg/ml
0 1 7 10 12 15 17 20 24 25 28 30 32 40 45 50 60 µg/well
102.53 94.63 94.34 70.79 53.50 53.50 50.37 49.63 39.34 27.72 -3.43
103.87 81.97 79.73 73.47 71.68 61.85 53.06 51.71 34.58 25.34 1.64
122.95 95.38 69.30 71.09 62.00 56.04 43.82 44.56 35.62 31.74 2.09
92.10 90.01 65.72 76.30 62.30 48.73 50.82 52.31 40.54 30.70 0.15
94.63 85.84 67.51 71.39 63.93 49.33 49.78 49.78 36.21 26.23 -4.62
101.64 80.48 69.15 68.26 63.64 54.10 52.31 48.73 33.83 22.50 -5.37
95.23 86.44 90.01 86.44 66.02 65.13 63.04 47.54 42.92 26.68 -2.09
86.89 89.72 81.22 78.69 46.94 57.08 53.65 37.11 33.68 19.23 6.11
93.70 71.85 70.59 69.12 47.69 41.60 34.24 17.23 8.19 -0.84 -1.68
79.41 47.48 55.25 36.13 40.55 35.71 30.67 -0.21 21.22 0.00 -9.66
94.54 62.39 63.66 61.34 50.84 40.97 36.34 25.63 28.15 5.04 -5.46
111.76 71.85 74.79 68.49 56.72 42.65 43.07 23.74 21.43 5.04 -4.62
122.48 85.50 78.57 69.75 54.20 55.04 40.13 28.36 21.64 15.55 -5.25
111.55 79.83 81.09 58.82 49.79 44.96 30.67 22.48 15.76 14.08 -6.51
113.87 76.89 69.96 75.42 59.87 51.47 43.28 24.79 13.87 18.91 -1.47
63.03 56.09 55.88 45.59 35.92 32.14 20.80 15.76 11.76 -3.99
101.09 77.72 86.96 76.09 65.76 70.65 20.65 7.07 22.28 10.33
76.63 68.48 75.54 75.00 65.22 76.63 32.61 4.89 39.67 -3.26
94.02 73.91 97.83 97.83 79.35 52.17 34.78 35.33 3.80
93.48 88.04 92.39 75.00 64.13 63.04 31.52 26.63 19.57 1.09
90.76 109.24 91.85 95.11 92.93 86.96 36.41 48.91 19.57 13.04
100.00 117.93 103.26 98.91 71.20 75.54 58.15 33.70 28.80 10.33
98.91 84.24 116.85 90.76 105.43 93.48 79.89 44.57 28.26
83.15 59.78 87.50 35.87 68.48 11.96 17.93 4.35
22 8 8 23 8 16 8 23 15 8 15 8 14 15 15 23 14 number
99.18 88.06 77.12 77.17 61.25 62.23 52.11 67.00 67.60 37.09 59.49 26.27 54.06 31.62 23.10 11.20 -0.24 Average
2.55 1.92 3.86 3.04 2.71 2.55 1.90 4.64 5.32 1.21 5.44 1.44 6.06 4.97 3.40 2.79 1.88 SE
11.95 5.42 10.91 14.57 7.66 10.21 5.37 22.26 20.59 3.43 21.07 4.08 22.66 19.23 13.16 13.36 7.04 SD
Experiments 0708JPAG, 071105JPAG Hangsterfer's S-506 CF MWF  CHO Cytotoxicity % NEGATIVE CONTROL
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 Table 11. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Hangsterfer’s  
S-506.  
 
Data source: Data 3 in MWF 073105.SNB   
Group Name N Missing Mean Std Dev SEM 
HS 0 µg/mL 22 0 99.184 11.947 2.547 
HS 5 µg/mL 8 0 88.059 5.419 1.916 
HS 35 µg/mL 8 0 77.124 10.910 3.857 
HS 50 µg/mL 24 0 77.415 14.304 2.920 
HS 60 µg/mL 8 0 61.252 7.661 2.709 
HS 75 µg/mL 16 0 62.235 10.207 2.552 
HS 85 µg/mL 8 0 52.105 5.368 1.898 
HS 100 µg/mL 23 0 67.000 22.260 4.641 
HS 120 µg/mL 16 0 67.108 19.991 4.998 
HS 125 µg/mL 8 0 37.090 3.432 1.213 
HS 140 µg/mL 16 0 61.240 21.530 5.382 
HS 150 µg/mL 8 0 26.267 4.080 1.443 
HS 160 µg/mL 15 0 52.848 22.335 5.767 
HS 200 µg/mL 16 0 33.919 20.738 5.185 
HS 225 µg/mL 16 0 22.407 13.020 3.255 
HS 250 µg/mL 24 0 11.477 13.140 2.682 
HS 300 µg/mL 15 0 0.0679 6.887 1.778 
 
Source of Variation DF SS MS F P 
Between Groups 16 198361.962 12397.623 52.199 <0.001 
Residual 234 55576.962 237.508   
Total 250 253938.924    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





HS 0 µg/mL vs. HS 250 µg/mL 87.708 19.281 0.000 0.003 Yes 
HS 0 µg/mL vs. HS 300 µg/mL 99.116 19.207 0.000 0.003 Yes 
HS 0 µg/mL vs. HS 225 µg/mL 76.777 15.163 0.000 0.004 Yes 
HS 0 µg/mL vs. HS 200 µg/mL 65.265 12.889 0.000 0.004 Yes 
HS 0 µg/mL vs. HS 150 µg/mL 72.917 11.460 0.000 0.004 Yes 
HS 0 µg/mL vs. HS 125 µg/mL 62.094 9.759 0.000 0.005 Yes 
HS 0 µg/mL vs. HS 160 µg/mL 46.336 8.979 0.000 0.005 Yes 
HS 0 µg/mL vs. HS 140 µg/mL 37.944 7.494 0.000 0.006 Yes 
HS 0 µg/mL vs. HS 85 µg/mL 47.079 7.399 0.000 0.006 Yes 
HS 0 µg/mL vs. HS 75 µg/mL 36.950 7.297 0.000 0.007 Yes 
HS 0 µg/mL vs. HS 100 µg/mL 32.184 7.003 0.000 0.009 Yes 
HS 0 µg/mL vs. HS 120 µg/mL 32.076 6.335 0.000 0.010 Yes 
HS 0 µg/mL vs. HS 60 µg/mL 37.932 5.962 0.000 0.013 Yes 
HS 0 µg/mL vs. HS 50 µg/mL 21.769 4.786 0.000 0.017 Yes 
HS 0 µg/mL vs. HS 35 µg/mL 22.061 3.467 0.001 0.025 Yes 
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 Syntilo 9904 
 
The summary data for the cytotoxicity assay for Syntilo 9904 is presented in Table 12 with the 




Table 12. Summary of CHO cell cytotoxicity of Syntilo 9904.  





















0 5 25 50 60 75 85 100 125 150 175 200 250 300 350 400 500 600 700 800 900 1000 µg/ml
106.90 120.04 117.15 119.15 112.25 87.53 49.44 54.12 70.16 23.39 30.51
106.24 101.11 92.20 87.97 108.02 79.51 68.15 66.82 54.79 25.17 32.29
111.58 103.34 94.88 90.65 85.08 67.04 55.23 62.36 55.23 43.88 34.52
106.90 98.44 86.64 80.40 83.74 73.05 63.47 60.80 55.68 38.75 42.32
96.88 84.41 98.44 92.87 78.17 75.95 66.82 47.44 38.98 34.97 39.64
113.14 79.73 81.74 79.73 69.49 71.94 56.79 39.87 36.30 9.35 26.95
92.87 65.26 75.06 78.17 51.45 52.34 64.37 46.55 21.38 9.80 36.75
76.75 108.49 95.94 74.17 57.56 46.49 40.22 31.37 24.72 25.46 32.10
94.10 81.18 95.57 63.10 77.49 66.05 37.27 40.22 29.89 15.13 27.31
90.04 86.35 75.65 73.43 61.62 55.35 48.34 38.38 31.73 19.56
112.18 92.25 97.79 78.97 64.21 52.77 52.77 52.77 21.03 19.93 13.28
95.94 91.88 70.48 74.17 70.48 54.61 45.39 34.32 29.15 25.09 23.99
108.49 94.10 67.90 53.87 73.43 39.85 45.39 33.21 14.02 11.44 11.81
116.24 98.52 85.24 73.80 79.34 74.54 38.38 31.00 25.46 32.10 29.89
101.39 76.14 89.07 53.88 50.70 34.59 25.25 12.33 13.32 3.38 -6.16
100.40 85.29 87.48 65.21 59.64 41.55 35.98 18.49 11.33 6.56 2.39
113.52 76.14 77.73 68.59 58.65 43.54 33.80 32.60 15.51 7.95 4.17
113.72 82.70 76.14 64.61 55.07 35.19 24.06 20.08 6.56 5.77 4.97
100.99 75.55 73.96 57.46 50.50 38.77 27.63 30.22 0.00 -4.17 5.77
93.84 87.08 75.15 43.34 55.47 25.25 23.66 11.53 -3.18 -7.36 0.20
96.82 85.69 54.27 56.66 34.19 28.43 13.72 9.94 0.60 -7.75 -1.59
20.00 7.00 14.00 14.00 7.00 7.00 7.00 21.00 7.00 7.00 7.00 14.00 14.00 14.00 7.00 14.00 14.00 7.00 7.00 7.00 7.00 7.00 number
102.94 93.19 93.04 87.73 84.03 72.48 60.61 68.58 47.50 70.85 26.47 66.41 39.84 48.64 26.09 37.51 28.95 26.30 19.31 6.31 0.62 1.39 Average
2.19 6.82 2.90 3.45 7.99 4.15 2.61 3.02 6.12 2.89 5.14 4.04 2.14 3.53 2.88 4.55 2.59 2.77 3.43 2.77 2.58 1.60 SE
9.80 18.04 10.84 12.89 21.14 10.98 6.90 13.85 16.19 7.64 13.59 15.13 8.00 13.20 7.62 17.04 9.68 7.34 9.07 7.32 6.83 4.24 SD
Experiment 031006B 033106B 040406B Syntilo 9904 MWF CHO Cytotoxicity % NEGATIVE CONTROL SUMMARY
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 Table 13. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Syntilo 9904. 
 
Data source: Data 9 in MWF 122706.SNB 
Group Name N Missing Mean Std Dev SEM 
Syntilo 0 µg/mL 20 0 102.944 9.803 2.192 
Syntilo 5 µg/mL 7 0 93.191 18.042 6.819 
Syntilo 25 µg/mL 14 0 93.040 10.842 2.898 
Syntilo 50 µg/mL 14 0 87.730 12.892 3.445 
Syntilo 60 µg/mL 7 0 84.028 21.136 7.989 
Syntilo 75 µg/mL 7 0 72.479 10.983 4.151 
Syntilo 85 µg/mL 7 0 60.611 6.902 2.609 
Syntilo 100 µg/mL 21 0 68.584 13.854 3.023 
Syntilo 125 µg/mL 7 0 47.502 16.193 6.121 
Syntilo 150 µg/mL 7 0 70.849 7.640 2.888 
Syntilo 175 µg/mL 7 0 26.472 13.590 5.136 
Syntilo 200 µg/mL 14 0 66.410 15.133 4.044 
Syntilo 250 µg/mL 14 0 39.839 8.001 2.138 
Syntilo 300 µg/mL 14 0 48.640 13.203 3.529 
Syntilo 350 µg/mL 7 0 26.094 7.618 2.879 
Syntilo 400 µg/mL 14 0 37.507 17.036 4.553 
Syntilo 500 µg/mL 14 0 28.946 9.681 2.587 
Syntilo 600 µg/mL 7 0 26.299 7.339 2.774 
Syntilo 700 µg/mL 7 0 19.313 9.075 3.430 
Syntilo 800 µg/mL 7 0 6.305 7.321 2.767 
Syntilo 900 µg/mL 7 0 0.625 6.830 2.581 
 
Source of Variation DF SS MS F P 
Between Groups 20 187024.544 9351.227 61.208 <0.001 
Residual 202 30861.004 152.777   
Total 222 217885.548    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant? 
Syntilo 0 µg/mL vs. Syntilo 900 µg/mL 102.320 18.850 2.133E-046 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 800 µg/mL 96.639 17.804 2.923E-043 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 500 µg/mL 73.998 17.180 2.263E-041 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 700 µg/mL 83.632 15.407 6.224E-036 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 400 µg/mL 65.437 15.193 2.865E-035 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 250 µg/mL 63.105 14.651 1.359E-033 0.003 Yes 
Syntilo 0 µg/mL vs. Syntilo 350 µg/mL 76.851 14.158 4.601E-032 0.004 Yes 
Syntilo 0 µg/mL vs. Syntilo 600 µg/mL 76.645 14.120 6.030E-032 0.004 Yes 
Syntilo 0 µg/mL vs. Syntilo 175 µg/mL 76.473 14.088 7.563E-032 0.004 Yes 
Syntilo 0 µg/mL vs. Syntilo 300 µg/mL 54.304 12.608 2.892E-027 0.005 Yes 
Syntilo 0 µg/mL vs. Syntilo 125 µg/mL 55.442 10.214 5.186E-020 0.005 Yes 
Syntilo 0 µg/mL vs. Syntilo 100 µg/mL 34.360 8.897 3.269E-016 0.006 Yes 
Syntilo 0 µg/mL vs. Syntilo 200 µg/mL 36.534 8.482 4.667E-015 0.006 Yes 
Syntilo 0 µg/mL vs. Syntilo 85 µg/mL 42.333 7.799 3.266E-013 0.007 Yes 
Syntilo 0 µg/mL vs. Syntilo 150 µg/mL 32.096 5.913 0.0000000141 0.009 Yes 
Syntilo 0 µg/mL vs. Syntilo 75 µg/mL 30.466 5.613 0.0000000652 0.010 Yes 
Syntilo 0 µg/mL vs. Syntilo 50 µ µg/mL 15.215 3.532 0.000510 0.013 Yes 
Syntilo 0 µg/mL vs. Syntilo 60 µg/mL 18.916 3.485 0.000604 0.017 Yes 
Syntilo 0 µg/mL vs. Syntilo 25 µg/mL 9.904 2.300 0.0225 0.025 Yes 






  Syntilo 9904 (µg/ml)























































 TrimE 20bnd 
 
The summary data for the CHO cell cytotoxicity assay for TrimE 20bnd is presented in Table 14 
and the statistical analysis is presented in Table 15. Figure 10 presents the cytotoxicity 




Table 14. Summary of CHO cell cytotoxicity of TrimE 20bnd.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
  
0 5 25 35 50 60 75 85 100 125 150 250 µg/ml
0 1 5 7 10 12 15 17 20 25 30 50 µg/well
117.53 102.30 84.20 79.31 -4.02
110.92 86.78 79.60 59.48 -2.87
82.47 70.11 67.53 64.08 0.86
72.70 74.71 62.07 80.46 0.29
89.37 92.53 76.44 57.47 0.29
101.72 80.46 68.68 61.21 -2.87
125.00 85.34 89.66 49.71 -3.45
99.14 101.72 93.68 44.54 -4.60
117.53 78.61 69.33 86.34 101.55 66.24 52.32 43.81 37.63 29.90 38.14
110.92 80.41 77.32 66.75 82.73 51.55 54.90 42.01 43.81 31.96 45.36
82.47 88.14 70.62 76.80 77.06 57.47 50.77 46.39 42.01 35.82 39.43
72.70 89.43 89.43 82.22 80.93 58.51 56.70 44.85 51.55 35.82 36.60
89.37 95.88 71.13 73.71 78.87 68.04 63.14 39.18 43.56 39.43 31.44
101.72 84.54 75.77 65.46 60.05 58.51 46.39 46.65 43.04 29.64 37.11
125.00 99.23 91.24 88.40 84.79 86.34 68.81 47.68 54.38 37.11 43.56
99.14 79.90 68.04 91.49 52.84 61.86 54.64 40.46 46.39 40.46 31.44
94.33 165.52 131.32 81.90 65.23 48.56 52.87 31.03 20.69 12.64 -2.59
87.89 128.45 90.80 69.83 70.98 38.22 52.87 29.60 16.09 4.31 8.62
91.24 111.49 74.71 54.02 45.69 43.68 23.28 29.31 8.33 11.21 6.03
83.51 102.30 72.41 58.05 52.87 36.49 29.60 20.98 13.22 9.77 2.01
100.26 119.25 77.30 59.48 50.29 38.51 29.02 25.57 25.00 11.21 6.90
92.78 97.99 72.70 47.99 57.76 35.92 33.33 22.70 26.15 15.52 0.86
112.63 125.00 94.54 73.28 60.06 44.25 42.24 27.01 20.40 14.94 5.75









32 24 16 16 24 16 16 16 16 16 16 16 number
99.89 98.10 77.17 82.95 67.61 60.12 48.24 40.44 35.62 26.51 24.78 1.24 Average
2.82 4.36 2.46 3.90 2.92 2.48 2.45 2.17 2.75 2.54 3.54 1.15 SE
Experiment 010405, 031505MPJP, 041205JPMP TrimE20BND MWF CHO Cytotoxicity % NEGATIVE CONTROL
27 
 
 Table 15. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of TrimE 20bnd.  
 
Data source: Data 6 in MWF 092506.SNB 
Group Name N Missing Mean Std Dev SEM 
TrimE20 0 µg/mL 32 0 99.887 15.931 2.816 
TrimE20 5 µg/mL 24 0 98.103 21.347 4.358 
TrimE20 25 µg/mL 16 0 77.170 9.838 2.459 
TrimE20 35 µg/mL 16 0 82.948 15.617 3.904 
TrimE20 50 µg/mL 24 0 67.606 14.312 2.922 
TrimE20 60 µg/mL 16 0 60.122 9.915 2.479 
TrimE20 75 µg/mL 16 0 48.239 9.816 2.454 
TrimE20 85 µg/mL 16 0 40.438 8.663 2.166 
TrimE20 100 µg/mL 16 0 35.615 10.989 2.747 
TrimE20 125 µg/mL 16 0 26.508 10.140 2.535 
TrimE20 150 µg/mL 16 0 24.780 14.174 3.543 
TrimE20 250 µg/mL 16 0 1.239 4.613 1.153 
 
Source of Variation DF SS MS F P 
Between Groups 11 211143.040 19194.822 104.604 <0.001 
Residual 212 38901.984 183.500   
Total 223 250045.024    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





TrimE20 0 µg/mL vs. TrimE20 250 µg/mL 98.648 23.784 9.410E-062 0.005 Yes 
TrimE20 0 µg/mL vs. TrimE20 150 µg/mL 75.107 18.108 6.472E-045 0.005 Yes 
TrimE20 0 µg/mL vs. TrimE20 125 µg/mL 73.379 17.692 1.271E-043 0.006 Yes 
TrimE20 0 µg/mL vs. TrimE20 100 µg/mL 64.272 15.496 1.019E-036 0.006 Yes 
TrimE20 0 µg/mL vs. TrimE20 85 µg/mL 59.449 14.333 5.000E-033 0.007 Yes 
TrimE20 0 µg/mL vs. TrimE20 75 µg/mL 51.648 12.452 4.486E-027 0.009 Yes 
TrimE20 0 µg/mL vs. TrimE20 60 µg/mL 39.765 9.587 2.589E-018 0.010 Yes 
TrimE20 0 µg/mL vs. TrimE20 50 µg/mL 32.281 8.825 4.119E-016 0.013 Yes 
TrimE20 0 µg/mL vs. TrimE20 25 µg/mL 22.717 5.477 0.000000122 0.017 Yes 
TrimE20 0 µg/mL vs. TrimE20 35 µg/mL 16.939 4.084 0.0000627 0.025 Yes 
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 Trim Sol 
 
The summary data for the cytotoxicity assay for Trim Sol is presented in Table 16 with the 




Table 16. Summary of CHO cell cytotoxicity of TrimSol.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 35 50 60 75 85 100 125 150 250 µg/ml
0 1 7 10 12 15 17 20 25 30 50 µg/well
121.80 121.45 111.42 96.54 72.66 80.28 38.41 34.26 25.95 16.26 6.57
121.45 97.58 102.08 90.31 69.90 51.21 40.14 39.45 26.64 11.42 3.81
98.96 102.08 87.54 75.09 62.63 53.98 43.25 37.02 19.03 10.38 3.81
89.27 97.23 80.97 62.28 55.71 61.25 14.88 10.03 1.73
98.96 88.24 90.66 77.16 49.48 56.40 68.86 23.88 14.53 9.69 -1.38
86.85 82.01 91.35 65.74 60.55 47.75 40.48 44.64 16.26 10.38 5.54
103.11 98.27 99.65 75.43 69.55 74.74 74.05 58.82 29.76 13.84 6.57
78.20 91.35 83.04 57.44 55.02 63.67 67.47 48.10 19.38 11.76 5.19
111.11 85.42 98.61 86.11 66.67 52.78 61.11 31.25 18.75 -0.69 -6.94
95.83 82.64 72.92 56.94 59.03 41.67 43.75 22.92 -2.08 -4.86 13.19
73.61 96.53 68.75 45.14 61.11 39.58 31.94 14.58 -3.47 -9.72 -11.11
97.22 89.58 67.36 55.56 48.61 49.31 21.53 9.72 0.69 -9.72 -14.58
96.53 82.64 68.75 62.50 52.78 47.22 27.78 22.92 -1.39 -4.17 -9.72
98.61 76.39 61.81 49.31 37.50 27.08 22.22 16.67 -2.08 -9.72 -10.42
140.97 97.92 83.33 67.36 65.28 34.03 41.67 36.11 14.58 6.25 4.86
86.81 125.69 81.94 46.53 40.97 17.36 23.61 22.22 4.17 -2.78 -10.42
16.000 16.000 16.000 16.000 16.000 16.000 15.000 15.000 16.000 16.000 16.000 number
99.96 94.69 84.39 66.84 57.97 49.89 43.09 30.84 12.23 3.65 -0.83 Average
4.293 3.369 3.546 3.872 2.557 4.054 4.483 3.507 2.826 2.322 2.102 SE
17.170 13.478 14.184 15.489 10.228 16.217 17.362 13.582 11.305 9.288 8.408 SD
Experiment  062105JPAG, 070505JP TrimSol MWF CHO Cytotoxicity PERCENT OF THE NEGATIVE CONTROL SUMMARY
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 Table 17. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Trim Sol.  
 
Data source: Data 1 in Notebook 1 
Group Name N Missing Mean Std Dev SEM 
TS 0 µg/mL 16 0 99.957 17.170 4.293 
TS 5 µg/mL 16 0 94.688 13.478 3.369 
TS 35 µg/mL 16 0 84.387 14.184 3.546 
TS 50 µg/mL 16 0 66.840 15.489 3.872 
TS 60 µg/mL 16 0 57.965 10.228 2.557 
TS 75 µg/mL 16 0 49.894 16.217 4.054 
TS 85 µg/mL 15 0 43.085 17.362 4.483 
TS 100 µg/mL 15 0 30.837 13.582 3.507 
TS 125 µg/mL 16 0 12.225 11.305 2.826 
TS 150 µg/mL 16 0 3.647 9.288 2.322 
TS 250 µg/mL 16 0 -0.832 8.408 2.102 
 
Source of Variation DF SS MS F P 
Between Groups 10 201083.335 20108.334 107.992 <0.001 
Residual 163 30350.954 186.202   
Total 173 231434.290    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





Level    
Significant? 
TS 0 µg/mL vs. TS 250 µg/mL 100.788 20.891 0.000 0.005 Yes 
TS 0 µg/mL vs. TS 150 µg/mL 96.310 19.963 0.000 0.006 Yes 
TS 0 µg/mL vs. TS 125 µg/mL 87.732 18.185 0.000 0.006 Yes 
TS 0 µg/mL vs. TS 100 µg/mL 69.120 14.094 0.000 0.007 Yes 
TS 0 µg/mL vs. TS 85 µg/mL 56.872 11.597 0.000 0.009 Yes 
TS 0 µg/mL vs. TS 75 µg/mL 50.063 10.377 0.000 0.010 Yes 
TS 0 µg/mL vs. TS 60 µg/mL 41.992 8.704 0.000 0.013 Yes 
TS 0 µg/mL vs. TS 50 µg/mL 33.117 6.864 0.000 0.017 Yes 
TS 0 µg/mL vs. TS 35 µg/mL 15.570 3.227 0.002 0.025 Yes 































































































%C½ = 73.2 µg/ml
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 Vita Edge 
 
The summary data for the cytotoxicity assay for Vita Edge is presented in Table 18 with the 




Table 18. Summary of CHO cell cytotoxicity of Vita Edge. The cell density is a percentage of the concurrent 






















0 5 10 20 25 30 35 40 50 60 75 85 100 125 150 250 µg/ml
0 1 2 4 5 6 7 8 10 12 15 17 20 25 30 50 µg/well
106.47 95.42 73.32 66.85 59.03 57.41 42.86 48.52 37.74 13.48 -9.43
93.73 102.43 95.15 72.51 69.00 77.90 51.21 50.94 35.58 4.85 -15.09
94.12 101.89 81.67 73.85 75.47 80.59 60.92 52.02 43.94 14.02 -14.02
88.43 108.63 94.61 86.79 77.09 71.70 67.65 54.72 23.45 5.39 -13.21
91.18 121.29 90.57 96.50 84.64 69.00 73.32 53.64 29.65 9.43 -15.36
101.57 108.63 96.50 73.32 77.90 71.16 61.46 46.36 12.13 -4.58 -14.82
119.02 104.85 94.34 86.79 98.11 64.96 53.91 47.17 32.88 11.86 -9.70
104.90 115.63 77.90 69.81 57.95 42.86 30.46 23.18 -3.50 -12.13
102.43 104.29 102.15 89.27 99.57 93.13 66.95 65.67 99.57 43.78 4.72
92.18 86.70 72.96 59.23 76.39 61.80 61.37 79.83 64.38 29.61 -9.44
74.39 85.41 81.12 68.67 100.43 73.82 86.27 111.16 53.22 29.61 0.86
83.83 76.82 70.82 75.97 84.55 83.69 89.27 93.56 56.65 30.90 -1.72
112.94 89.02 70.39 65.24 71.67 130.90 100.86 81.97 46.78 29.18 3.86
97.84 89.02 73.39 60.09 84.55 93.13 81.12 73.82 47.21 12.45 -0.86
128.57 97.84 81.97 75.11 78.54 81.97 116.31 53.65 73.39 28.76 -11.59
108.09 110.39 61.80 56.22 87.98 54.51 58.37 32.19 44.21 24.46 0.86
115.45 100.20 69.41 38.43 18.63 -0.98 8.63 11.57 0.78 1.37 3.92
112.45 101.76 65.29 48.82 16.27 5.29 7.25 10.59 -0.39 0.00 2.75
100.43 90.78 70.20 63.92 40.20 -0.59 9.22 16.67 0.98 3.14 0.20
85.84 92.16 69.41 67.65 24.31 -3.53 5.10 -2.75 -0.20 0.20 3.53
94.85 73.14 67.45 38.43 7.65 8.43 0.20 -0.98 1.37 -1.37
83.26 86.47 63.14 55.29 10.59 9.41 10.20 -5.69 -2.94 -2.94
111.59 76.08 56.86 46.08 23.73 6.86 3.92 1.96 1.18 -1.76
95.28 80.20 62.75 50.00 13.73 -1.76 -4.12 -6.08 -4.31 -4.51
24 20 16 16 16 15 24 16 24 24 24 8 8 8 8 8 number
99.95 99.16 82.41 73.51 80.18 77.71 71.04 60.98 49.71 23.70 -2.55 6.64 5.78 -1.20 0.00 -0.02 Average
2.63 2.48 2.95 2.87 3.17 4.83 3.50 5.48 3.95 3.36 2.11 1.30 2.67 1.07 0.87 1.11 SE
12.87 11.09 11.80 11.47 12.70 18.71 17.13 21.92 19.34 16.47 10.34 3.68 7.56 3.03 2.46 3.15 SD
Experiment 070805JPAG 072205JPAG VitaEdge MWF  CHO Cytotoxicity % NEGATIVE CONTROL
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 Table 19. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Vita Edge. 
 
Data source: Data 2 in MWF 073105.SNB 
Group Name N Missing Mean Std Dev SEM 
VE 0 µg/mL 24 0 99.951 12.873 2.628 
VE 5 µg/mL 20 0 99.158 11.086 2.479 
VE 10 µg/mL 16 0 82.415 11.797 2.949 
VE 20 µg/mL 16 0 73.513 11.467 2.867 
VE 25 µg/mL 16 0 80.180 12.700 3.175 
VE 30 µg/mL 15 0 77.712 18.715 4.832 
VE 35 µg/mL 24 0 71.037 17.133 3.497 
VE 40 µg/mL 16 0 60.980 21.925 5.481 
VE 50 µg/mL 24 0 49.707 19.340 3.948 
VE 60 µg/mL 24 0 23.705 16.473 3.363 
VE 75 µg/mL 24 0 -2.550 10.338 2.110 
 
Source of Variation DF SS MS F P 
Between Groups 10 220685.599 22068.560 94.074 <0.001 
Residual 208 48793.957 234.586   
Total 218 269479.556    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





VE 0 µg/mL vs. VE 75 µg/mL 102.501 23.183 0.000 0.005 Yes 
VE 0 µg/mL vs. VE 60 µg/mL 76.246 17.245 0.000 0.006 Yes 
VE 0 µg/mL vs. VE 50 µg/mL 50.244 11.364 0.000 0.006 Yes 
VE 0 µg/mL vs. VE 40 µg/mL 38.971 7.884 0.000 0.007 Yes 
VE 0 µg/mL vs. VE 35 µg/mL 28.914 6.540 0.000 0.009 Yes 
VE 0 µg/mL vs. VE 20 µg/mL 26.438 5.348 0.000 0.010 Yes 
VE 0 µg/mL vs. VE 30 µg/mL 22.239 4.411 0.000 0.013 Yes 
VE 0 µg/mL vs. VE 25 µg/mL 19.771 4.000 0.000 0.017 Yes 
VE 0 µg/mL vs. VE 10 µg/mL 17.536 3.547 0.000 0.025 Yes 




 Vita Edge (µg/ml)























































 Alusol AU39 
 
The summary data for the CHO cell cytotoxicity assay for Alusol AU39 is presented in Table 20 
and the statistical analysis is presented in Table 21. Figure 13 presents the cytotoxicity 




Table 20. Summary of CHO cell cytotoxicity of Alusol AU39.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 25 50 60 75 85 100 125 150 175 200 225 250 µg/ml
0 1 5 10 12 15 17 20 25 30 35 40 45 50 µg/well
100.58 89.36 67.70 30.17 15.67 15.47 11.99 2.71 -0.77 -5.42 -14.89
96.13 78.92 50.87 16.05 16.05 15.28 3.48 -0.19 -8.70 -8.32 -10.06
104.84 83.56 65.96 28.43 10.25 11.61 2.71 1.16 -7.74 -11.99 -11.03
111.41 92.46 59.96 37.14 6.19 9.67 1.35 1.35 -5.22 -13.54 -10.64
91.68 74.85 58.99 32.30 5.61 9.48 -2.51 -1.74 -6.38 -9.28 -14.31
90.52 76.60 54.16 30.17 10.25 16.05 16.05 0.19 -4.64 -10.44 -12.96
111.80 90.72 49.90 18.76 6.38 7.35 11.61 3.48 -3.29 -5.42 -2.51
93.04 88.20 38.30 0.39 -4.26 -4.45 -7.35 -12.19 -14.12 -15.67 -13.93
96.76 87.78 44.14 34.91 11.47 7.98 -2.00 -7.73 -5.49 -8.48 -10.72
90.52 76.06 38.65 22.44 6.48 1.00 -3.49 -7.48 -6.98 -8.23 -7.23
101.75 59.10 24.19 19.20 6.73 0.75 -0.75 -4.49 -7.73 -8.98 -7.73
110.22 53.87 39.90 10.22 1.75 -21.95 -4.99 -8.73 -12.97 -11.22 -16.21
96.51 70.07 55.61 6.98 6.98 -2.24 -2.24 0.50 -10.22 -5.74 -7.48
111.22 59.60 16.46 16.46 -6.73 2.00 -9.73 -6.23 -10.47 -12.72 -9.23
107.48 79.05 34.41 15.71 14.71 14.21 -5.24 3.99 -4.99 -4.74 2.99
85.04 73.07 34.16 0.50 0.50 0.75 -19.70 -8.98 -7.73 -6.23 -3.24
16 8 16 16 8 16 8 16 16 8 16 8 8 16 number
99.97 84.33 62.78 30.06 8.27 12.93 4.67 2.29 -3.02 -6.02 -7.45 -8.32 -8.29 -9.32 Average
2.18 2.42 3.14 3.25 2.30 2.25 2.81 1.61 2.09 2.18 1.22 0.96 0.96 1.28 SE
8.72 6.83 12.56 13.01 6.49 8.98 7.96 6.44 8.36 6.18 4.86 2.71 2.73 5.10 SD







 Table 21. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Alusol AU39.  
 
Data source: Data 12 in MWF 040107.SNB 
Group Name N Missing Mean Std Dev SEM 
Alusol 0 µg/mL 16 0 99.969 8.723 2.181 
Alusol 5 µg/mL 8 0 84.333 6.831 2.415 
Alusol 25 µg/mL 16 0 62.778 12.560 3.140 
Alusol 50 µg/mL 16 0 30.060 13.011 3.253 
Alusol 60 µg/mL 8 0 8.269 6.492 2.295 
Alusol 75 µg/mL 16 0 12.931 8.980 2.245 
Alusol 85 µg/mL 8 0 4.666 7.961 2.815 
Alusol 100 µg/mL 16 0 2.292 6.445 1.611 
Alusol 125 µg/mL 16 0 -3.024 8.359 2.090 
Alusol 150 µg/mL 8 0 -6.016 6.178 2.184 
Alusol 175 µg/mL 16 0 -7.452 4.865 1.216 
Alusol 200 µg/mL 8 0 -8.323 2.712 0.959 
Alusol 225 µg/mL 8 0 -8.292 2.728 0.964 
Alusol 250 µg/mL 16 0 -9.324 5.100 1.275 
 
Source of Variation DF SS MS F P 
Between Groups 13 227614.625 17508.817 255.328 <0.001 
Residual 162 11108.948 68.574   
Total 175 238723.572    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





Alusol 0 µg/mL vs. Alusol 250 µg/mL 109.293 37.330 1.773E-081 0.004 Yes 
Alusol 0 µg/mL vs. Alusol 175 µg/mL 107.421 36.691 2.170E-080 0.004 Yes 
Alusol 0 µg/mL vs. Alusol 125 µg/mL 102.992 35.178 9.333E-078 0.005 Yes 
Alusol 0 µg/mL vs. Alusol 100 µg/mL 97.677 33.362 1.773E-074 0.005 Yes 
Alusol 0 µg/mL vs. Alusol 200 µg/mL 108.292 30.201 1.943E-068 0.006 Yes 
Alusol 0 µg/mL vs. Alusol 225 µg/mL 108.261 30.192 2.021E-068 0.006 Yes 
Alusol 0 µg/mL vs. Alusol 75 µg/mL 87.038 29.729 1.692E-067 0.007 Yes 
Alusol 0 µg/mL vs. Alusol 150 µg/mL 105.985 29.557 3.732E-067 0.009 Yes 
Alusol 0 µg/mL vs. Alusol 85 µg/mL 95.302 26.578 5.960E-061 0.010 Yes 
Alusol 0 µg/mL vs. Alusol 60 µg/mL 91.700 25.573 9.282E-059 0.013 Yes 
Alusol 0 µg/mL vs. Alusol 50 µg/mL 69.909 23.878 6.130E-055 0.017 Yes 
Alusol 0 µg/mL vs. Alusol 25 µg/mL 37.191 12.703 4.270E-026 0.025 Yes 






 Alusol AU39 (µg/ml)






























































 Castrol Clearedge 6536 
 
The summary data for the cytotoxicity assay for Castrol Clearedge 6536 is presented in Table 22 





Table 22. Summary of CHO cell cytotoxicity of Castrol Clearedge 6536. 
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 15 25 30 40 50 60 75 100 125 µg/ml
0 1 3 5 6 8 10 12 15 20 25 µg/well
83.85 71.14 36.29 76.86 58.86 57.71 50.29 8.86 2.29 -2.86 -9.14
91.75 30.29 26.57 54.00 52.29 35.14 33.43 3.71 -2.00 -1.71 -2.29
111.68 39.43 31.71 83.14 50.86 35.14 41.43 0.86 -12.86 -10.57 -3.71
114.43 38.29 31.14 63.71 54.00 71.14 51.43 -10.29 9.71 -11.71 6.86
104.81 58.57 28.57 64.86 52.86 39.14 33.43 -7.14 -17.14 -16.29 -9.71
105.50 44.00 38.00 61.43 64.86 35.14 29.14 -6.00 -9.14 -7.71 -6.57
109.62 65.43 34.57 47.43 63.71 21.14 31.43 -9.14 -3.71 -6.29 -10.00
78.35 27.71 31.14 59.43 48.29 14.00 51.71 -15.71 -5.14 -10.00 -9.14
71.43 82.92 65.55 56.30 53.63 42.75 19.56 15.46 8.78 -2.00 -0.10
75.71 92.65 62.31 67.37 43.80 38.93 25.48 19.37 4.96 -0.29 1.43
102.57 88.26 68.70 68.89 66.22 50.00 22.33 19.37 6.39 3.82 2.58
110.29 84.45 62.69 75.19 74.05 52.00 20.80 10.11 10.69 3.44 -1.81
126.29 90.27 67.18 69.66 59.64 50.57 15.55 4.10 9.45 -1.91 -3.24
105.43 88.36 75.10 71.76 56.20 55.82 19.94 6.39 13.55 -0.57 -0.38
118.57 73.09 73.95 56.39 49.14 50.57 21.56 7.25 11.35 7.06 2.77









24 16 16 16 16 16 16 16 16 16 16 number
100.03 64.92 49.38 64.23 55.79 44.08 30.47 3.24 1.27 -3.61 -2.69 Average
1.42 5.68 4.59 2.47 2.09 3.60 3.06 2.64 2.38 1.58 1.27 SE
13.64 22.71 18.38 9.88 8.34 14.39 12.24 10.56 9.54 6.32 5.07 SD








 Table 23. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Castrol Clearedge 6536. 
  
Data source: Data 13 in MWF 040107.SNB 
Group Name N Missing Mean Std Dev SEM 
Cast6536 0 µg/mL 24 0 100.032 13.642 2.785 
Cast6536 5 µg/mL 16 0 64.918 22.714 5.679 
Cast6536 15 µg/mL 16 0 49.385 18.376 4.594 
Cast6536 25 µg/mL 16 0 64.234 9.879 2.470 
Cast6536 30 µg/mL 16 0 55.785 8.342 2.085 
Cast6536 40 µg/mL 16 0 44.083 14.390 3.598 
Cast6536 50 µg/mL 16 0 30.472 12.244 3.061 
Cast6536 60 µg/mL 16 0 3.242 10.558 2.639 
Cast6536 75 µg/mL 16 0 1.275 9.540 2.385 
Cast6536 100 µg/mL 16 0 -3.612 6.324 1.581 
Cast6536 125 µg/mL 16 0 -2.690 5.070 1.268 
 
Source of Variation DF SS MS F P 
Between Groups 10 218130.471 21813.047 130.263 <0.001 
Residual 173 28969.601 167.454   
Total 183 247100.072    
   
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





Cast6536 0 µg/mL vs. Cast6536 100 µg/mL 103.644 24.816 6.875E-059 0.005 Yes 
Cast6536 0 µg/mL vs. Cast6536 125 µg/mL 102.722 24.595 2.296E-058 0.006 Yes 
Cast6536 0 µg/mL vs. Cast6536 75 µg/mL 98.757 23.646 4.409E-056 0.006 Yes 
Cast6536 0 µg/mL vs. Cast6536 60 µg/mL 96.789 23.175 6.247E-055 0.007 Yes 
Cast6536 0 µg/mL vs. Cast6536 50 µg/mL 69.560 16.655 8.742E-038 0.009 Yes 
Cast6536 0 µg/mL vs. Cast6536 40 µg/mL 55.949 13.396 1.560E-028 0.010 Yes 
Cast6536 0 µg/mL vs. Cast6536 15 µg/mL 50.647 12.127 6.875E-025 0.013 Yes 
Cast6536 0 µg/mL vs. Cast6536 30 µg/mL 44.246 10.594 1.574E-020 0.017 Yes 
Cast6536 0 µg/mL vs. Cast6536 25 µg/mL 35.798 8.571 5.541E-015 0.025 Yes 






























































 IRMCO Cutting Fluid Product A 
 
The summary data for the cytotoxicity assay for IRMCO Cutting Fluid Product A is presented in 
Table 24 with the statistical analysis presented in Table 25 and the concentration-response curve 




Table 24. Summary of CHO cell cytotoxicity of IRMCO Cutting Fluid Product A.  





















0 5 25 50 60 75 85 100 125 175 200 250 300 350 400 450 500 550 600 700 800 µg/ml
0 1 5 10 12 15 17 20 25 35 40 50 60 70 80 90 100 110 120 140 160 µg/well
80.81 110.35 91.16 89.90 84.34 75.25 54.80 50.51 66.16 47.47 42.68
71.21 103.54 103.79 95.20 90.15 84.85 83.08 70.96 73.48 60.35 46.97
82.58 112.63 115.15 119.19 103.54 100.25 94.95 82.83 73.99 69.19 59.34
95.71 106.57 107.58 108.59 101.01 84.85 91.67 80.05 66.41 66.41 55.30
120.96 102.27 127.27 115.15 110.61 96.72 98.99 79.55 67.68 58.33 47.73
131.06 110.86 107.83 102.78 100.00 71.21 69.44 72.73 62.12 51.01 38.89
129.80 103.28 116.67 104.55 96.46 88.89 67.17 58.08 48.48 43.18 51.77
85.37 82.66 85.91 67.75 65.58 61.25 52.85 18.16 -7.05 5.96 -6.78
102.71 90.24 81.57 85.09 69.11 76.15 69.38 44.44 15.18 15.45 -4.07
99.73 125.47 76.15 111.92 86.99 97.29 67.21 46.34 18.70 3.25 1.63
103.52 138.21 82.93 123.04 83.74 113.01 76.69 47.97 27.37 6.23 -0.54
108.67 86.18 71.27 72.09 72.36 72.90 68.83 27.10 7.32 -0.81 -7.05
83.85 88.89 79.95 87.53 86.18 89.97 75.88 46.88 14.63 9.21 -1.36
91.75 77.78 97.29 70.73 52.57 77.51 23.58 -0.27 4.61 0.81
111.68 94.85 84.19 90.72 53.61 83.51 70.79 65.29 51.89 50.52
114.43 75.26 82.13 111.00 68.38 89.35 61.86 50.52 49.83 19.24 32.99
104.81 99.31 100.34 100.34 100.69 80.41 70.79 66.32 61.51 37.80 26.80
105.50 87.97 91.07 86.94 73.88 89.35 66.67 51.55 49.14 32.99 23.71
109.62 106.53 102.75 92.10 83.51 88.32 73.54 53.26 55.33 46.05 15.81
78.35 82.13 83.51 89.35 58.42 65.98 56.70 45.36 57.39 26.12 16.49
101.03 114.78 76.63 67.35 76.63 68.73 59.45 57.73 31.96 6.19
95.53 84.19 60.14 60.48 58.76 49.48 35.40 45.02 29.21 20.62
20.00 7.00 7.00 21.00 7.00 7.00 7.00 22.00 7.00 7.00 22.00 15.00 15.00 8.00 15.00 7.00 15.00 8.00 7.00 7.00 7.00 number
100.61 107.07 109.92 99.51 98.02 86.00 80.01 81.51 65.48 56.57 77.03 73.40 79.70 64.82 61.03 53.71 35.32 24.14 10.84 6.27 -2.48 Average
3.77 1.59 4.29 3.38 3.28 3.97 6.25 2.91 3.25 3.67 5.20 3.26 4.12 2.92 3.23 2.21 2.92 4.71 4.43 1.92 1.33 SE
16.86 4.21 11.35 15.50 8.69 10.51 16.54 13.63 8.59 9.72 24.40 12.63 15.97 8.25 12.49 5.84 11.31 13.33 11.72 5.08 3.52 SD
Experiment 040706bJP, 041406bJP, 041806bJP MWF CHO Cytotoxicity SUMMARY % NEG CONTROL IRMCO CUT PRODUCT A
42 
 
 Table 25. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of IRMCO Cutting Fluid 
Product A.  
 
Data source: Data 11 in MWF 040107.SNB 
Group Name  N Missing Mean Std Dev SEM 
Irmco 0 µg/mL 20 0 100.606 16.861 3.770 
Irmco 5 µg/mL 7 0 107.071 4.205 1.589 
Irmco 25 µg/mL 7 0 109.921 11.353 4.291 
Irmco 50 µg/mL 21 0 99.506 15.502 3.383 
Irmco 60 µg/mL 7 0 98.016 8.690 3.284 
Irmco 75 µg/mL 7 0 86.003 10.513 3.974 
Irmco 85 µg/mL 7 0 80.014 16.537 6.250 
Irmco 100 µg/mL 22 0 81.509 13.628 2.905 
Irmco 125 µg/mL 7 0 65.476 8.590 3.247 
Irmco 175 µg/mL 7 0 56.566 9.717 3.673 
Irmco 20 0µg/mL 22 0 77.028 24.395 5.201 
Irmco 250 µg/mL 15 0 73.401 12.633 3.262 
Irmco 300 µg/mL 15 0 79.696 15.971 4.124 
Irmco 350 µg/mL 8 0 64.820 8.245 2.915 
Irmco 400 µg/mL 15 0 61.033 12.494 3.226 
Irmco 450 µg/mL 7 0 53.706 5.841 2.208 
Irmco 500 µg/mL 15 0 35.315 11.312 2.921 
Irmco 550 µg/mL 8 0 24.141 13.330 4.713 
Irmco 600 µg/mL 7 0 10.840 11.719 4.429 
Irmco 700 µg/mL 7 0 6.272 5.083 1.921 
Irmco 800 µg/mL 7 0 -2.478 3.525 1.332 
 
Source of Variation DF SS MS F P 
Between Groups 20 200591.931 10029.597 49.451 <0.001 
Residual 217 44011.536 202.818   
Total 237 244603.467    
   
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant? 
Irmco 0 µg/mL vs. Irmco 800 µg/mL 103.084 16.482 4.046E-040 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 700 µg/mL 94.334 15.083 1.224E-035 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 600 µg/mL 89.766 14.353 2.720E-033 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 500 µg/mL 65.291 13.422 2.637E-030 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 550 µg/mL 76.465 12.835 1.986E-028 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 400 µg/mL 39.573 8.135 3.156E-014 0.003 Yes 
Irmco 0 µg/mL vs. Irmco 450 µg/mL 46.900 7.499 1.626E-012 0.004 Yes 
Irmco 0 µg/mL vs. Irmco 175 µg/mL 44.040 7.042 2.470E-011 0.004 Yes 
Irmco 0 µg/mL vs. Irmco 350 µg/mL 35.786 6.007 0.00000000789 0.004 Yes 
Irmco 0 µg/mL vs. Irmco 125 µg/mL 35.130 5.617 0.0000000592 0.005 Yes 
Irmco 0 µg/mL vs. Irmco 250 µg/mL 27.205 5.593 0.0000000669 0.005 Yes 
Irmco 0 µg/mL vs. Irmco 200 µg/mL 23.578 5.359 0.000000213 0.006 Yes 
Irmco 0 µg/mL vs. Irmco 100 µg/mL 19.097 4.340 0.0000218 0.006 Yes 
Irmco 0 µg/mL vs. Irmco 300 µg/mL 20.910 4.299 0.0000260 0.007 Yes 
Irmco 0 µg/mL vs. Irmco 85 µg/mL 20.592 3.292 0.00116 0.009 Yes 
Irmco 0 µg/mL vs. Irmco 75 µg/mL 14.603 2.335 0.0205 0.010 No 
Irmco 0 µg/mL vs. Irmco 25 µg/mL 9.315 1.489 0.138 0.013 No 
Irmco 0 µg/mL vs. Irmco 5 µg/mL 6.465 1.034 0.302 0.017 No 
Irmco 0 µg/mL vs. Irmco 60 µg/mL 2.590 0.414 0.679 0.025 No 




 Irmco Cutting Fluid Product A (µg/ml)























































 MWF Components 
Bunsan 77 
 
The summary data for the CHO cell cytotoxicity assay for Busan 77 MWF component is 
presented in Table 26 and the statistical analysis is presented in Table 27. Figure 16 presents the 




Table 26. Summary of CHO cell cytotoxicity of Busan 77.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 10 20 25 35 45 50 60 75 100 µg/ml
0 1 2 4 5 7 9 10 12 15 20 µg/well
89.92 73.01 46.70 2.91 -9.97 -12.77
66.74 89.70 67.75 2.46 -2.46 -10.19
83.43 76.60 65.29 7.84 2.91 -5.38
100.22 88.91 69.65 13.66 -2.69 -7.28
110.97 96.30 85.78 9.41 1.57 -3.25
105.71 100.90 88.58 20.72 1.57 -5.49
125.42 104.37 104.70 27.66 7.39 -4.93
117.81 82.42 28.33 9.29 -6.05
115.81 102.72 116.29 77.48 70.61 53.99 44.25 23.48 10.38 0.00 -12.46
92.17 103.67 116.45 85.30 81.63 48.88 41.21 9.27 -2.40 -1.60 -10.38
97.92 108.63 98.40 87.38 101.60 55.91 44.41 17.25 -3.67 -3.99 -9.74
101.44 106.55 94.89 104.95 74.92 68.69 36.26 7.03 -7.51 -6.71 -11.18
104.15 102.88 94.09 74.60 69.81 75.08 49.68 1.44 -4.95 -16.45 -15.65
91.85 89.94 90.42 77.32 73.32 54.15 17.89 1.12 -13.90 -13.26 -13.90
96.33 92.33 85.94 84.66 62.30 50.80 41.21 -4.47 2.72 -12.46 -11.98
153.94 54.55 105.45 31.52 31.52 17.58 27.27 -11.52 -9.70 -13.33 4.24
66.06 60.61 56.97 36.97 31.52 5.45 3.03 -16.97 -9.09 -15.15 -9.09
63.64 53.33 40.61 33.94 26.06 17.58 -6.06 -20.61 -15.76 -12.12 -9.09
61.21 51.52 41.21 27.88 32.12 9.70 -3.64 -5.45 -35.15 -31.52 -8.48
127.88 38.18 101.82 50.91 49.09 -0.61 -29.09 -24.24 -22.42 -20.61
48.48 34.55 17.58 9.70 -7.88 -3.03 -27.88 -24.85 -29.09 -28.48
150.30 36.97 73.94 28.48 7.88 -4.24 -30.30 -14.55 -16.36 -17.58 -14.55
127.88 104.85 105.45 33.33 13.33 1.21 -6.06 -24.85 -22.42 -21.82 -22.42
23.00 23.00 15.00 15.00 22.00 15.00 13.00 23.00 15.00 23.00 23.00 number
99.97 80.59 82.63 56.29 56.65 30.08 19.94 0.75 -11.79 -9.13 -10.83 Average
5.73 5.21 7.79 7.56 6.51 7.40 7.17 3.63 3.05 2.31 1.42 SE
27.50 24.99 30.16 29.28 30.53 28.66 25.86 17.41 11.83 11.08 6.82 SD








 Table 27. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Busan 77. 
 
Data source: Data 14 in MWF 092207.SNB 
Group Name   N Missing Mean Std Dev SEM 
Busan77 0 µg/mL 23 0 99.969 27.502 5.735 
Busan77 5 µg/mL 23 0 80.585 24.985 5.210 
Busan77 10 µg/mL 15 0 82.634 30.162 7.788 
Busan77 20 µg/mL 15 0 56.295 29.279 7.560 
Busan77 25 µg/mL 22 0 56.648 30.532 6.509 
Busan77 35 µg/mL 15 0 30.076 28.662 7.400 
Busan77 45 µg/mL 13 0 19.936 25.855 7.171 
Busan77 50 µg/mL 23 0 0.748 17.412 3.631 
Busan77 60 µg/mL 15 0 -11.794 11.828 3.054 
 
Source of Variation  DF   SS   MS    F    P  
Between Groups 8 227093.336 28386.667 42.784 <0.001 
Residual 155 102839.629 663.481   
Total 163 329932.966    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





Busan77 0 µg/mL vs. Busan77 60 µg/mL 111.763 13.074 8.470E-027 0.006 Yes 
Busan77 0 µg/mL vs. Busan77 50 µg/mL 99.222 13.063 9.063E-027 0.007 Yes 
Busan77 0 µg/mL vs. Busan77 45 µg/mL 80.034 8.955 1.003E-015 0.009 Yes 
Busan77 0 µg/mL vs. Busan77 35 µg/mL 69.893 8.176 9.818E-014 0.010 Yes 
Busan77 0 µg/mL vs. Busan77 25 µg/mL 43.321 5.640 0.0000000787 0.013 Yes 
Busan77 0 µg/mL vs. Busan77 20 µg/mL 43.675 5.109 0.000000940 0.017 Yes 
Busan77 0 µg/mL vs. Busan77 5 µg/mL 19.384 2.552 0.0117 0.025 Yes 




 Busan 77 MWF Component (µg/mL)





















































 UCON EMPL-48 
 
The summary data for the cytotoxicity assay for UCON EMPL-48 MWF component is presented 
in Table 28 with the statistical analysis presented in Table 29 and the concentration-response 




Table 28. Summary of CHO cell cytotoxicity of UCON EMPL-48.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 25 50 75 100 125 150 175 200 225 250 300 350 400 µg/ml
0 1 5 10 15 20 25 30 35 40 45 50 60 70 80 µg/well
89.00 92.76 83.65 61.79 50.51 42.11 27.50 27.50 27.79 21.85 -7.38
90.45 83.07 92.91 89.87 80.61 58.61 47.76 41.39 36.90 29.96 -1.59
91.32 93.92 88.57 94.21 74.53 76.70 60.35 55.72 36.61 37.92 7.38
106.37 81.48 103.18 98.26 93.63 89.44 54.99 51.52 46.02 33.43 19.25
102.89 103.18 116.64 97.40 104.49 84.37 72.50 52.68 48.91 47.32 33.86
112.59 100.58 109.12 105.35 119.83 82.05 58.76 55.14 44.28 44.72 35.46
107.38 107.38 113.75 106.66 84.52 83.07 72.94 66.43 63.24 61.36 52.53
88.94 98.12 90.01 78.58 55.43 63.53 54.27 45.88 41.39 44.28 53.11
94.18 122.84 92.91 87.23 72.34 58.44 62.84 62.98 50.07 44.26 40.85
127.80 160.14 126.67 128.37 106.52 93.62 95.32 71.21 47.38 47.80 43.55
101.13 160.14 117.16 121.70 89.65 82.98 82.27 75.60 58.87 50.64 47.94
97.59 139.29 118.16 101.28 82.55 104.82 72.91 54.18 69.22 61.28 35.60
95.46 129.36 110.78 86.52 87.09 87.09 61.99 63.12 56.31 60.28 38.16
95.18 124.11 103.83 97.87 77.59 68.37 58.30 41.84 44.11 48.51 36.60
109.41 104.68 92.34 88.65 68.51 67.94 66.52 43.55 49.79 41.84 42.27
63.53 97.06 108.24 49.41 47.06 62.94 54.71 47.06 74.71 44.12 32.94
68.24 106.47 85.88 80.59 95.29 66.47 64.71 61.18 40.00 80.00 41.18
70.59 82.94 76.47 82.35 54.12 64.12 59.41 54.12 38.82 43.53 50.59
73.53 77.65 97.65 84.71 94.12 62.35 68.82 55.29 41.18 39.41 33.53
120.00 97.65 77.65 93.53 132.94 64.12 77.06 54.71 35.88 38.82 27.65
151.76 114.12 77.65 131.18 72.35 82.35 69.41 48.24 37.65 38.24 25.29
142.35 110.59 128.82 87.06 78.82 72.94 72.35 57.65 43.53 30.59 41.76
57.06 47.06 87.06 51.18 133.53 67.65 91.76 59.41 29.41 36.47
22 8 23 8 15 23 15 23 23 23 15 23 15 8 8 number
99.99 95.06 107.91 91.52 95.03 86.56 68.89 71.97 63.96 58.35 60.66 44.23 43.74 43.01 36.18 Average
4.74 3.25 5.15 5.28 5.92 4.65 4.99 4.94 5.10 4.73 2.61 4.62 2.69 5.61 2.91 SE
22.25 9.20 24.71 14.94 22.93 22.32 19.32 23.69 24.46 22.68 10.10 22.14 10.44 15.87 8.22 SD







 Table 29. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of UCON EMPL-48.  
 
Data source: Data 15 in MWF 092207.SNB 
Group Name  N Missing Mean Std Dev SEM 
UCON-48 0 µg/mL 22 0 99.986 22.250 4.744 
UCON-48 5 µg/mL 8 0 95.062 9.200 3.253 
UCON-48 25 µg/mL 23 0 107.910 24.712 5.153 
UCON-48 50 µg/mL 8 0 91.516 14.935 5.280 
UCON-48 75 µg/mL 15 0 95.025 22.926 5.920 
UCON-48 100 µg/mL 23 0 86.562 22.323 4.655 
UCON-48 125 µg/mL 15 0 68.888 19.319 4.988 
UCON-48 150 µg/mL 23 0 71.973 23.694 4.941 
UCON-48 175 µg/mL 23 0 63.964 24.461 5.100 
UCON-48 200 µg/mL 23 0 58.354 22.681 4.729 
UCON-48 225 µg/mL 15 0 60.657 10.096 2.607 
UCON-48 250 µg/mL 23 0 44.227 22.140 4.617 
UCON-48 300 µg/mL 15 0 43.743 10.436 2.695 
UCON-48 350 µg/mL 8 0 43.015 15.867 5.610 
UCON-48 400 µg/mL 8 0 36.176 8.217 2.905 
 
Source of Variation DF SS MS F P 
Between Groups 14 121460.835 8675.774 20.092 <0.001 
Residual 237 102335.528 431.795   
Total 251 223796.363    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P 
Critical 
Level Significant? 
UCON-48 0 µg/mL vs. UCON-48 250 µg/mL 55.759 8.998 7.621E-017 0.004 Yes 
UCON-48 0 µg/mL vs. UCON-48 300 µg/mL 56.243 8.083 3.231E-014 0.004 Yes 
UCON-48 0 µg/mL vs. UCON-48 400  µg/mL 63.810 7.438 1.868E-012 0.004 Yes 
UCON-48 0 µg/mL vs. UCON-48 200  µg/mL 41.632 6.718 0.000000000135 0.005 Yes 
UCON-48 0 µg/mL vs. UCON-48 350 µg/mL 56.971 6.641 0.000000000211 0.005 Yes 
UCON-48 0 µg/mL vs. UCON-48 175 µg/mL 36.022 5.813 0.0000000197 0.006 Yes 
UCON-48 0 µg/mL vs. UCON-48 225  µg/mL 39.329 5.652 0.0000000453 0.006 Yes 
UCON-48 0 µg/mL vs. UCON-48 150 µg/mL 28.013 4.521 0.00000974 0.007 Yes 
UCON-48 0 µg/mL vs. UCON-48 125 µg/mL 31.099 4.469 0.0000122 0.009 Yes 
UCON-48 0 µg/mL vs. UCON-48 100 µg/mL 13.424 2.166 0.0313 0.010 No 
UCON-48 0 µg/mL vs. UCON-48 25 µg/mL 7.924 1.279 0.202 0.013 No 
UCON-48 0 µg/mL vs. UCON-48 50 µg/mL 8.470 0.987 0.324 0.017 No 
UCON-48 0 µg/mL vs. UCON-48 75 µg/mL 4.961 0.713 0.477 0.025 No 




 UCON EMPL-48 MWF Component (µg/mL)

























































The summary data for the CHO cell cytotoxicity assay for the MWF component AMP95 is 
presented in Table 30 and the statistical analysis is presented in Table 31. Figure 18 presents the 




Table 30. Summary of CHO cell cytotoxicity of AMP95.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
Summary of Experiments with AMP95 MWF Component 
0 5 25 50 75 100 125 150 175 200 μg/mL 
0 1 5 10 15 20 25 30 35 40 μg/well 
99.73 108.94 56.37 65.04 65.04 61.79 53.39 46.07 47.15 31.71  
109.76 128.46 117.89 79.95 94.31 61.25 68.83 42.82 69.65 44.72  
92.14  112.20 92.68 77.78 69.92 64.50 64.77 33.33 31.17  
96.21 125.47 102.71 92.68 75.61 69.92 50.68 44.99 38.75 26.83  
96.75 131.71 92.41 78.05 90.24 75.07 72.63 61.25 40.11 19.51  
101.63 110.84 78.32 66.94 62.06 64.77 52.30 42.01 15.18 7.05  
105.96 92.95 105.96 77.78 62.06 60.16 62.87 33.60 38.21 13.01  
97.02 82.93 59.35 49.86 39.30 52.57 54.47 25.75 -0.81 12.74  
100.00  131.40 125.07 133.25 101.32 98.15 104.22 65.17 84.43  
101.06 106.33 114.25 130.61 149.34 106.86 105.28 83.91 62.01 40.11  
95.51 121.11 135.88 123.75 109.76 100.79 100.00 75.73 65.44 40.11  
98.42  136.41 121.37 107.39 98.42 89.97 80.21 54.62 32.19  
102.11 123.48 145.38 122.16 122.96 102.90 88.39 75.20 91.56 37.99  
99.74 111.35 115.83 115.57 122.69 88.65 115.83 82.59 90.24 26.65  
103.96 112.93 122.43 106.33 98.94 83.91 73.88 98.42 64.12 23.48  
99.21 86.54 84.43 82.06 107.92 87.86 82.59 98.68 26.39 22.96  
16 13 16 16 16 16 16 16 16 16 Number 
99.95 111.00 106.95 95.62 94.91 80.38 77.11 66.26 50.07 30.91 Average 
1.07 4.34 6.67 6.35 7.47 4.52 5.18 6.19 6.31 4.46 SE 






 Table 31. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of AMP95.  
 
Data source: Data 16 in MWF 092207.SNB 
Group Name  N Missing Mean Std Dev SEM 
AMP95 0 µg/mL 16 0 99.949 4.271 1.068 
AMP95 5 µg/mL 16 3 111.003 15.660 4.343 
AMP95 25 µg/mL 16 0 106.951 26.683 6.671 
AMP95 50 µg/mL 16 0 95.618 25.414 6.353 
AMP95 75 µg/mL 16 0 94.915 29.871 7.468 
AMP95 100 µg/mL 16 0 80.385 18.093 4.523 
AMP95 125 µg/mL 16 0 77.110 20.708 5.177 
AMP95 150 µg/mL 16 0 66.262 24.767 6.192 
AMP95 175 µg/mL 16 0 50.069 25.254 6.314 
AMP95 200 µg/mL 16 0 30.915 17.852 4.463 
 
Source of Variation DF SS MS F P 
Between Groups 9 93898.513 10433.168 21.343 <0.001 
Residual 147 71858.907 488.836   
Total 156 165757.420    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P 
Critical 
Level Significant? 
AMP95 0 µg/mL vs. AMP95 200 µg/mL 69.034 8.831 2.855E-015 0.006 Yes 
AMP95 0 µg/mL vs. AMP95 175 µg/mL 49.881 6.381 0.00000000216 0.006 Yes 
AMP95 0 µg/mL vs. AMP95 150 µg/mL 33.687 4.310 0.0000298 0.007 Yes 
AMP95 0 µg/mL vs. AMP95 125 µg/mL 22.839 2.922 0.00403 0.009 Yes 
AMP95 0 µg/mL vs. AMP95 100 µg/mL 19.564 2.503 0.0134 0.010 No 
AMP95 0 µg/mL vs. AMP95 5 µg/mL 11.054 1.339 0.183 0.013 No 
AMP95 0 µg/mL vs. AMP95 25 µg/mL 7.002 0.896 0.372 0.017 No 
AMP95 0 µg/mL vs. AMP95 75 µg/mL 5.034 0.644 0.521 0.025 No 


































Figure 18. CHO cell chronic cytotoxicity concentration-response curve for AMP95. 
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The summary data for the cytotoxicity assay for the MWF component UCON 50-HB-6 is 
presented in Table 32 with the statistical analysis presented in Table 33 and the concentration-




Table 32. Summary of CHO cell cytotoxicity of UCON 50-HB-6.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 5 25 50 75 100 125 150 175 200 225 250 300 350 400 µg/ml 
0 1 5 10 15 20 25 30 35 40 45 50 60 70 80 µg/well 
106.03 102.01 100.00 102.30 104.02 103.16 121.84 97.99 88.51 77.30  54.89 75.84 64.61 56.46  
95.40 106.32 109.20 108.62 115.52 96.26 97.70 95.69 92.53 73.56  66.09 72.19 67.70 64.61  
92.82 118.10 118.97 123.56 110.92 104.89 99.14 97.70 91.09 81.03  56.90 88.48 66.57 58.71  
101.15 118.68 115.23 98.56 102.87 95.69 104.02 94.54 87.07 72.70  52.01 81.74 71.07 55.06  
113.51 99.14 114.37 111.49 100.86 101.44 93.39 87.64 89.37 75.29  50.00 78.09 67.70 56.74  
97.13 90.80 106.32 103.16 98.28 101.72 83.91 94.83 77.87 62.64  50.57 73.88 64.04 57.87  
100.29 114.37 94.54 106.03 97.99 87.07 88.51 66.09 68.68 61.78  54.02 73.60 64.89 62.64  
93.39  135.39   135.96  110.96 109.83 88.48 92.98 80.06 57.02 54.78 50.56  
111.80  105.90   117.70  120.79 99.16 109.55 103.09 82.02     
84.27  104.21   122.47  119.66 101.12 95.22 85.96 79.78     
78.93  121.35   126.40  109.55 105.06 99.44 104.21 96.07     
97.75  125.00   115.17  112.92 107.02 110.39 85.96 81.18     
100.00  114.61   107.58  142.13 97.75 89.04 104.78 89.04     
101.69  120.51   109.83  112.92 96.07 85.96 100.28 87.64     
118.26  89.61   91.29  83.99 73.60 81.18 66.57 77.25     
107.87                
16 7 15 7 7 15 7 15 15 15 8 15 8 8 8 number 
100.02 107.06 111.68 107.68 104.35 107.78 98.36 103.16 92.31 84.24 92.98 70.50 75.11 65.17 57.83 Average 
2.56 3.97 3.11 3.09 2.48 3.51 4.66 4.69 3.10 3.83 4.66 4.16 3.19 1.68 1.54 SE 
10.26 10.51 12.05 8.19 6.57 13.62 12.34 18.19 12.02 14.84 13.18 16.12 9.03 4.76 4.3 SD 
 Table 33. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of UCON 50-HB-6.  
 
Data source: Data 17 in MWF 092207.SNB 
Group Name  N Missing Mean Std Dev SEM 
 HB-6 0 µg/mL 16 0 100.017 10.258 2.565 
 HB-6 5 µg/mL 7 0 107.061 10.515 3.974 
 HB-6 25 µg/mL 15 0 111.680 12.054 3.112 
 HB-6 50 µg/mL 7 0 107.677 8.195 3.097 
 HB-6 75 µg/mL 7 0 104.351 6.579 2.487 
 HB-6 100 µg/mL 15 0 107.776 13.628 3.519 
 HB-6 125 µg/mL 7 0 98.358 12.349 4.668 
 HB-6 150 µg/mL 15 0 103.160 18.191 4.697 
 HB-6 175 µg/mL 15 0 92.315 12.022 3.104 
 HB-6 200 µg/mL 15 0 84.239 14.847 3.834 
 HB-6 225 µg/mL 8 0 92.978 13.185 4.662 
 HB-6 250 µg/mL 15 0 70.501 16.125 4.163 
 HB-6 300 µg/mL 8 0 75.105 9.037 3.195 
 HB-6 350 µg/mL 8 0 65.169 4.769 1.686 
 HB-6 400 µg/mL 8 0 57.830 4.366 1.544 
 
Source of Variation  DF   SS   MS    F    P  
Between Groups 14 42234.440 3016.746 19.046 <0.001 
Residual 151 23917.044 158.391   
Total 165 66151.484    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P 
Critical 
Level Significant? 
 HB-6 0 µg/mL vs.  HB-6 400 µg/mL 42.187 7.741 1.315E-012 0.004 Yes 
 HB-6 0 µg/mL vs.  HB-6 250 µg/mL 29.516 6.526 0.000000000967 0.004 Yes 
 HB-6 0 µg/mL vs.  HB-6 350 µg/mL 34.849 6.395 0.00000000190 0.004 Yes 
 HB-6 0 µg/mL vs.  HB-6 300 µg/mL 24.912 4.571 0.0000100 0.005 Yes 
 HB-6 0 µg/mL vs.  HB-6 200 µg/mL 15.778 3.488 0.000637 0.005 Yes 
 HB-6 0 µg/mL vs.  HB-6 25 µg/mL 11.662 2.578 0.0109 0.006 No 
 HB-6 0 µg/mL vs.  HB-6 100 µg/mL 7.758 1.715 0.0883 0.006 No 
 HB-6 0 µg/mL vs.  HB-6 175 µg/mL 7.702 1.703 0.0906 0.007 No 
 HB-6 0 µg/mL vs.  HB-6 50 µg/mL 7.659 1.343 0.181 0.009 No 
 HB-6 0 µg/mL vs.  HB-6 225 µg/mL 7.040 1.292 0.198 0.010 No 
 HB-6 0 µg/mL vs.  HB-6 5 µg/mL 7.044 1.235 0.219 0.013 No 
 HB-6 0 µg/mL vs.  HB-6 75 µg/mL 4.334 0.760 0.448 0.017 No 
 HB-6 0 µg/mL vs.  HB-6 150 µg/mL 3.143 0.695 0.488 0.025 No 
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 Alkaterg T-IV 
 
The summary data for the CHO cell cytotoxicity assay for the MWF component Alkaterg T-IV is 
presented in Table 34 and the statistical analysis is presented in Table 35. Figure 20 presents the 




Table 34. Summary of CHO cell cytotoxicity of Alkaterg T-IV.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 1 2.5 5 10 15 20 25 50 µg/ml
0 0.2 0.5 1 2 3 4 5 10 µg/well
101.04 138.72 94.53 109.11 41.67 2.60
92.19 109.57 105.92 88.80 23.18 3.91
97.40 125.51 105.99 20.83 1.82
104.17 147.61 94.53 10.16 -4.17
113.80 125.74 102.08 10.16 3.91
99.48 131.89 121.41 94.01 8.59 -1.04
92.19 101.82 84.74 80.47 10.94 -2.08
96.46 73.12 64.69 67.97 10.42 -3.39
105.32 92.15 84.56 56.20 34.68 5.32 -7.85
114.68 83.29 86.33 49.37 17.47 1.77 -8.10
97.47 86.33 79.24 47.09 26.33 9.11 -8.10
108.86 83.80 79.75 47.59 15.95 5.32 -4.56
96.46 82.78 80.76 39.75 12.41 7.09 -6.33
97.72 91.39 85.82 36.71 17.97 4.81 -5.57
83.54 83.29 73.92 38.73 18.23 13.67 -2.28








23.00 7.00 6.00 16.00 8.00 8.00 8.00 16.00 15.00 number
100.01 118.32 99.51 88.49 78.61 43.13 19.43 11.60 -2.75 Average
2.20 9.64 9.42 2.85 3.22 2.99 2.67 2.48 1.09 SE
10.56 25.50 23.08 11.40 9.11 8.45 7.55 9.91 4.24 SD






 Table 35. Statistical analysis of the CHO cell cytotoxicity data of AlkatergT-IV.  
 
Data source: Data 18 in MWF 010108.SNB 
Group Name  N Missing Mean Std Dev SEM 
Alkaterg 0 µg/mL 23 0 100.014 10.563 2.203 
Alkaterg 1 µg/mL 7 0 118.321 25.501 9.638 
Alkaterg 2.5 µg/mL 6 0 99.506 23.083 9.424 
Alkaterg 5 µg/mL 16 0 88.493 11.404 2.851 
Alkaterg 10 µg/mL 8 0 78.608 9.106 3.219 
Alkaterg 15 µg/mL 8 0 43.133 8.451 2.988 
Alkaterg 20 µg/mL 8 0 19.430 7.545 2.668 
Alkaterg 25 µg/mL 16 0 11.597 9.910 2.477 
Alkaterg 50 µg/mL 15 0 -2.748 4.238 1.094 
 
Source of Variation  DF   SS   MS    F    P  
Between Groups 8 197745.762 24718.220 170.897 <0.001 
Residual 98 14174.532 144.638   
Total 106 211920.294    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





Alkaterg 0 µg/mL vs. Alkaterg 50 µg/mL 102.762 25.746 2.094E-045 0.006 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 25 µg/mL 88.416 22.583 1.264E-040 0.007 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 20 µg/mL 80.583 16.324 1.047E-029 0.009 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 15 µg/mL 56.881 11.523 6.257E-020 0.010 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 10 µg/mL 21.406 4.336 0.0000352 0.013 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 1 µg/mL 18.307 3.526 0.000642 0.017 Yes 
Alkaterg 0 µg/mL vs. Alkaterg 5 µg/mL 11.521 2.943 0.00406 0.025 Yes 












































Figure 20. Concentration-response curve for the CHO cell chronic cytotoxicity of Alkaterg T-IV. 
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 Actramide 202 
 
The summary data for the cytotoxicity assay for Actramide 202 MWF component is presented in 
Table 36 with the statistical analysis presented in Table 37 and the concentration-response curve 




Table 36. Summary of CHO cell cytotoxicity of Actramide 202.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 1 2.5 5 6 7 8 9 10 12.5 15 µg/ml









95.39 91.13 36.52 4.26
107.80 83.69 10.64 -0.35
101.06 80.85 11.35 -1.06
108.51 85.11 -0.71 -6.38
101.42 89.36 7.09 1.42
96.81 74.11 16.67 -5.67
89.72 73.05 15.60 -0.35
2.84 -0.71
88.51 131.03 152.71 117.57 102.63 139.90 82.59 73.89 59.28 57.80 8.70
93.60 123.32 130.21 119.87 80.30 99.01 90.48 94.09 63.38 34.98 9.03
107.22 93.43 101.64 79.64 87.52 74.55 93.60 93.60 69.13 26.77 1.64
123.15 119.54 101.48 95.07 85.22 74.88 73.40 73.56 57.80 20.85 -3.28
84.40 113.46 89.66 74.88 77.01 88.18 77.18 79.64 61.08 33.17 0.33
105.75 90.48 76.68 76.19 78.98 65.02 55.50 57.64 57.96 12.81 2.79
97.37 112.15 94.75 82.43 84.24 58.46 70.11 66.01 98.52 28.90 9.36
22 7 7 21 7 7 7 7 15 7 15 number
100.07 111.92 106.73 91.01 85.13 85.71 77.55 76.92 37.81 30.75 1.31 Average
2.29 5.69 9.83 3.41 3.24 10.39 4.90 5.10 7.92 5.33 1.26 SE
10.76 15.04 26.00 15.65 8.56 27.48 12.97 13.49 30.66 14.11 4.89 SD






 Table 37. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Actramide 202.   
 
Data source: Data 19 in MWF 010108.SNB 
Group Name  N Missing Mean Std Dev SEM 
Actramide 0 µg/mL 22 0 100.065 10.759 2.294 
Actramide 1 µg/mL 7 0 111.916 15.041 5.685 
Actramide 2.5 µg/mL  0 106.732 26.003 9.828 
Actramide 5 µg/mL 21 0 91.006 15.645 3.414 
Actramide 6 µg/mL 7 0 85.128 8.561 3.236 
Actramide 7 µg/mL 7 0 85.714 27.485 10.388 
Actramide 8 µg/mL 7 0 77.551 12.967 4.901 
Actramide 9 µg/mL 7 0 76.918 13.488 5.098 
Actramide 10 µg/mL 15 0 37.811 30.659 7.916 
Actramide 12.5 µg/mL 7 0 30.753 14.110 5.333 
Actramide 15 µg/mL 15 0 1.314 4.894 1.264 
 
Source of Variation  DF   SS   MS    F    P  
Between Groups 10 151779.456 15177.946 48.829 <0.001 
Residual 111 34503.176 310.839   
Total 121 186282.632    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  






Actramide 0 µg/mL vs. Actramide 15 µg/mL 98.751 16.728 4.080E-032 0.005 Yes 
Actramide 0 µg/mL vs. Actramide 10 µg/mL 62.255 10.545 1.975E-018 0.006 Yes 
Actramide 0 µg/mL vs. Actramide 12.5 µg/mL 69.312 9.059 5.209E-015 0.006 Yes 
Actramide 0 µg/mL vs. Actramide 9 µg/mL 23.148 3.026 0.00308 0.007 Yes 
Actramide 0 µg/mL vs. Actramide 8 µg/mL 22.514 2.943 0.00396 0.009 Yes 
Actramide 0 µg/mL vs. Actramide 6 µg/mL 14.937 1.952 0.0534 0.010 No 
Actramide 0 µg/mL vs. Actramide 7 µg/mL 14.351 1.876 0.0633 0.013 No 
Actramide 0 µg/mL vs. Actramide 5 µg/mL 9.060 1.684 0.0949 0.017 No 
Actramide 0 µg/mL vs. Actramide 1 µg/mL 11.851 1.549 0.124 0.025 No 
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 Dover Mayfree 133 
 
The summary data for the CHO cell cytotoxicity assay for the MWF component Dover Mayfree 
133 is presented in Table 38 and the statistical analysis is presented in Table 39. Figure 22 




Table 38. Summary of CHO cell cytotoxicity of Dover Mayfree 133.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 1 10 15 20 25 30 33 35 36 37 38 39 40 45 50 µg/ml
0 0.2 2 3 4 5 6 6.6 7 7.2 7.4 7.6 7.8 8 9 10 µg/well
112.65 118.24 101.76 30.44 50.82 47.31 35.60 21.31 13.58 17.56 12.88 -6.04
97.66 94.71 95.88 46.60 49.88 36.07 15.93 28.34 15.93 17.56 5.15 3.75 -6.65
91.10 102.35 115.00 32.08 45.90 31.62 28.34 16.39 21.08 8.90 7.49 -4.22 -8.46
89.23 86.18 105.00 14.29 48.95 37.00 25.29 22.25 17.80 11.01 -1.64 -11.24 -7.55
93.44 94.56 83.99 76.13 18.74 40.52 51.52 26.23 14.75 15.93 -0.23 3.04 -7.96 -5.44
92.97 84.89 93.05 84.29 38.41 44.73 34.89 27.87 27.87 16.39 14.75 3.75 7.26 -5.74
107.73 93.66 105.14 100.30 45.43 57.61 47.54 40.28 32.79 27.63 13.58 14.29 14.75 -2.34 3.93
114.99 122.36 121.75 116.01 42.62 48.71 40.05 41.69 37.00 26.70 21.55 23.42 22.01 7.03 2.42
116.47 125.38 127.19 119.03 80.97 57.40 49.24 46.83 5.14 -3.63
101.76 128.10 113.60 108.76 83.38 66.16 59.82 50.76 8.76 -7.55
83.82 128.70 100.00 101.00 85.20 83.08 60.42 48.34 2.42 -7.55
98.24 137.76 124.77 120.54 107.55 96.68 80.97 60.12 13.29 -5.14
110.00 112.39 95.47 80.97 52.87 13.90 -4.83
87.65 98.79 80.06 71.60 69.79 15.11 -5.44
107.65 112.69 89.73 82.78 81.27 19.34 4.53









24 4 12 8 8 16 15 16 15 8 8 8 8 16 10 8 number
99.92 100.37 111.09 108.69 103.26 66.18 63.71 55.31 45.07 26.87 20.35 12.59 9.13 7.90 -2.34 -4.19 Average
1.95 6.81 4.98 5.57 5.75 8.98 5.12 4.47 4.73 2.97 1.67 2.28 3.00 2.37 1.60 1.65 SE
9.58 13.62 17.26 15.76 16.26 35.91 19.85 17.87 18.32 8.41 4.72 6.46 8.47 9.49 5.05 4.67 SD





 Table 39. Statistical analysis (one way repeated measures ANOVA) of the CHO cell cytotoxicity data of Dover 
Mayfree 133.  
 
Data source: Data 20 in MWF 040108.SNB 
Treatment Name  N Missing Mean Std Dev SEM 
DMF133 0µg/mL 24 0 99.916 9.577 1.955 
DMF133 1µg/mL 4 0 100.368 13.622 6.811 
DMF133 10µg/mL 12 0 111.088 17.257 4.982 
DMF133 15µg/mL 8 0 108.686 15.759 5.572 
DMF133 20µg/mL 8 0 103.259 16.257 5.748 
DMF133 25µg/mL 16 0 66.184 35.905 8.976 
DMF133 30µg/mL 15 0 63.713 19.845 5.124 
DMF133 33µg/mL 16 0 55.307 17.874 4.468 
DMF133 35µg/mL 15 0 45.068 18.315 4.729 
DMF133 36µg/mL 8 0 26.874 8.408 2.973 
DMF133 37µg/mL 8 0 20.345 4.723 1.670 
DMF133 38µg/mL 8 0 12.588 6.461 2.284 
DMF133 39µg/mL 8 0 9.133 8.472 2.995 
DMF133 40µg/mL 16 0 7.898 9.488 2.372 
DMF133 45µg/mL 10 0 -2.341 5.049 1.597 
  
Source of Variation  DF   SS   MS    F    P  
Between Subjects 23 24704.516 1074.109   
Between Treatments 14 237148.015 16939.144 105.339 <0.001 
Residual 138 22191.312 160.807   
Total 175 302330.531 1727.603   
  
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). To isolate the group or groups that differ from the others use a 
multiple comparison procedure. 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  







DMF133 0 µg/mL vs. DMF133 40 µg/mL   92.033 20.527 8.949E-044 0.004 Yes 
DMF133 0 µg/mL vs. DMF133 45 µg/mL 92.149 17.692 2.641E-037 0.004 Yes 
DMF133 0 µg/mL vs. DMF133 39 µg/mL 77.249 13.731 1.375E-027 0.004 Yes 
DMF133 0 µg/mL vs. DMF133 38 µg/mL 73.795 13.117 5.000E-026 0.005 Yes 
DMF133 0 µg/mL vs. DMF133 35 µg/mL 53.898 11.779 1.339E-022 0.005 Yes 
DMF133 0 µg/mL vs. DMF133 37 µg/mL 66.037 11.738 1.704E-022 0.006 Yes 
DMF133 0 µg/mL vs. DMF133 36 µg/mL 59.509 10.578 1.619E-019 0.006 Yes 
DMF133 0 µg/mL vs. DMF133 33 µg/mL 44.623 9.953 6.346E-018 0.007 Yes 
DMF133 0 µg/mL vs. DMF133 30 µg/mL 35.252 7.704 2.318E-012 0.009 Yes 
DMF133 0 µg/mL vs. DMF133 25 µg/mL 33.746 7.527 6.089E-012 0.010 Yes 
DMF133 0 µg/mL vs. DMF133 15 µg/mL 22.303 3.964 0.000118 0.013 No 
DMF133 0 µg/mL vs. DMF133 10 µg/mL  17.495 3.566 0.000498 0.017 No 
DMF133 0 µg/mL vs. DMF133 20 µg/mL  16.877 3.000 0.00321 0.025 No 


























Figure 22. CHO cell chronic cytotoxicity concentration-response curve for Dover Mayfree 133. 
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 Cover Sulperm HO 
 
The summary data for the cytotoxicity assay for Dover Sulperm HO MWF component is 
presented in Table 40 with the statistical analysis presented in Table 41 and the concentration-




Table 40. Summary of CHO cell cytotoxicity of Dover Sulperm HO.  





0 1 10 50 100 150 200 250 300 325 350 375 400 425 450 460 470 480 500 550 600 µg/ml
0 0.2 2 10 20 30 40 50 60 65 70 75 80 85 90 92 94 96 100 110 120 µg/well
105.68 94.32 115.91 101.89 101.14 101.14 103.41 105.44 62.50 91.19 71.21 65.03 55.30 72.80 49.74 21.76 21.56 21.18 39.39 3.82 -8.29
94.70 107.58 113.64 96.97 117.42 95.45 84.09 100.78 82.95 73.83 60.98 75.65 48.48 52.07 51.55 21.95 18.89 8.21 29.17 -1.72 -11.14
88.64 110.23 112.50 109.85 113.26 98.11 88.64 104.40 48.11 90.41 41.67 76.68 18.18 62.44 54.66 24.24 23.66 21.95 21.21 1.15 -10.36
95.08 102.27 124.62 119.32 116.29 105.30 87.50 95.34 50.38 87.31 50.76 68.13 28.41 61.40 59.84 24.24 31.11 30.34 24.24 0.38 -10.36
96.59 99.48 104.92 84.97 106.22 63.99 93.26 58.29 81.61 57.25 25.76 42.18 35.69 15.84 0.19 -11.40
93.94 93.78 98.70 92.75 111.40 72.02 69.69 63.73 57.77 33.16 28.05 34.54 41.22 9.92 -1.91 -14.77
117.42 96.89 127.46 85.75 94.04 87.05 79.79 69.17 65.28 68.13 46.37 52.48 54.39 4.20 3.82 -7.25
107.95 89.38 85.75 106.99 87.82 93.01 80.57 78.50 62.44 68.13 58.02 56.11 52.10 20.61 1.72 -8.03
105.96 103.11 104.92 104.40 86.79 21.18 24.24 12.60
81.87 95.08 115.80 79.02 51.30 37.98 35.50 21.56
97.41 131.35 108.29 80.57 63.99 35.50 30.15 36.07
92.75 115.80 83.94 61.92 53.37 37.79 34.92 27.86
97.15 43.70 38.93 33.21 46.18 35.69
92.75 56.11 50.95 42.37 61.26 51.72
112.44 61.07 39.69 36.64 61.45 56.68
120.21 53.82 44.47 47.33 50.76 58.02
102.10 59.73 41.98 33.21
90.08 74.81 53.44 18.32
88.55 73.47 70.23 57.44





24.00 4.00 4.00 4.00 4.00 4.00 12.00 8.00 20.00 8.00 20.00 8.00 20.00 16.00 16.00 8.00 8.00 8.00 12.00 8.00 8.00 number
100.04 103.60 116.67 107.01 112.03 100.00 99.04 102.85 75.09 92.78 63.42 76.10 50.66 54.24 48.09 31.30 35.07 33.13 21.89 0.93 -10.20 Average
2.20 3.51 2.74 4.89 3.74 2.11 3.86 4.20 5.03 4.12 4.20 3.15 4.21 3.86 3.46 4.74 4.98 5.64 2.99 0.77 0.85 SE
10.80 7.02 5.49 9.77 7.47 4.23 13.37 11.89 22.49 11.65 18.79 8.91 18.82 15.44 13.83 13.42 14.07 15.95 10.37 2.18 2.40 SD
Experiment 050608MPEW, 051308MPEW, 052008MPEW PL1 Dover Sulperm ho MWF  CHO Cytotoxicity % NEGATIVE CONTROL SUMMARY
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 Table 41. Statistical analysis (one way repeated measures ANOVA) of the CHO cell cytotoxicity data of Dover 
Sulperm HO.   
 
Data source: Data 21 in MWF 060908.SNB 
Treatment Name  N Missing Mean Std Dev SEM 
DSho 0 µg/mL 24 0 100.037 10.798 2.204 
DSho 1 µg/mL 4 0 103.598 7.015 3.508 
DSho 10 µg/mL 4 0 116.667 5.489 2.745 
DSho 50 µg/mL 4 0 107.008 9.773 4.886 
DSho 100 µg/mL 4 0 112.027 7.470 3.735 
DSho 150 µg/mL 4 0 100.000 4.229 2.115 
DSho 200 µg/mL 12 0 99.042 13.372 3.860 
DSho 250 µg/mL 8 0 102.850 11.889 4.203 
DSho 300 µg/mL 20 0 75.089 22.487 5.028 
DSho 325 µg/mL 8 0 92.778 11.652 4.120 
DSho 350 µg/mL 20 0 63.425 18.795 4.203 
DSho 375 µg/mL 8 0 76.101 8.912 3.151 
DSho 400 µg/mL 20 0 50.655 18.821 4.209 
DSho 425 µg/mL 16 0 54.244 15.439 3.860 
DSho 450 µg/mL 16 0 48.087 13.829 3.457 
DSho 460 µg/mL 8 0 31.298 13.419 4.744 
DSho 470 µg/mL 8 0 35.067 14.073 4.976 
DSho 480 µg/mL 8 0 33.135 15.949 5.639 
DSho 500 µg/mL 12 0 21.890 10.370 2.994 
DSho 550 µg/mL 8 0 0.930 2.179 0.771 
 
Source of Variation DF SS MS F P 
Between Subjects 23 11196.498 486.804   
Between Treatments 19 190063.458 10003.340 54.368 <0.001 
Residual 173 31830.686 183.992   
Total 215 233981.675 1088.287   
   
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). To isolate the group or groups that differ from the others use a 
multiple comparison procedure. 
 
Power of performed test with alpha = 0.050:1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





DSho 0 µg/mL vs. DSho 550 µg/mL 101.606 17.331 1.165E-039 0.003 Yes 
DSho 0 µg/mL vs. DSho 500 µg/mL 81.192 16.001 5.924E-036 0.003 Yes 
DSho 0 µg/mL vs. DSho 460 µg/mL 71.238 12.151 5.847E-025 0.003 Yes 
DSho 0 µg/mL vs. DSho 480 µg/mL 69.402 11.838 4.613E-024 0.003 Yes 
DSho 0 µg/mL vs. DSho 470 µg/mL 67.469 11.508 4.030E-023 0.003 Yes 
DSho 0 µg/mL vs. DSho 450 µg/mL 52.268 11.332 1.281E-022 0.004 Yes 
DSho 0 µg/mL vs. DSho 400 µg/mL 47.911 11.169 3.712E-022 0.004 Yes 
DSho 0 µg/mL vs. DSho 425 µg/mL 46.111 9.997 7.359E-019 0.004 Yes 
DSho 0 µg/mL vs. DSho 350 µg/mL 35.141 8.192 5.462E-014 0.005 Yes 
DSho 0 µg/mL vs. DSho 300 µg/mL 23.477 5.473 0.000000153 0.005 Yes 
DSho 0 µg/mL vs. DSho 375 µg/mL 26.435 4.509 0.0000120 0.006 Yes 
DSho 0 µg/mL vs. DSho 10 µg/mL 20.083 2.617 0.00966 0.006 No 
DSho 0 µg/mL vs. DSho 100 µg/mL 15.443 2.012 0.0458 0.007 No 
DSho 0 µg/mL vs. DSho 325 µg/mL 9.758 1.664 0.0979 0.009 No 
DSho 0 µg/mL vs. DSho 50 µg/mL 10.424 1.358 0.176 0.010 No 
DSho 0 µg/mL vs. DSho 1 µg/mL 7.015 0.914 0.362 0.013 No 
DSho 0 µg/mL vs. DSho 200 µg/mL 4.039 0.796 0.427 0.017 No 
DSho 0 µg/mL vs. DSho 150 µg/mL 3.416 0.445 0.657 0.025 No 



























Figure 23. CHO cell chronic cytotoxicity concentration-response curve for Dover Sulperm HO. 
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 Dover Maylube E112 
 
The summary data for the CHO cell cytotoxicity assay for the MWF component Dover Maylube 
E112 is presented in Table 42 and the statistical analysis is presented in Table 43. Figure 24 




Table 42. Summary of CHO cell cytotoxicity of Dover Maylube E112.  
The cell density is a percentage of the concurrent negative control for each microplate. 
 
0 10 50 100 150 175 200 225 250 275 300 350 450 µg/ml
0 2 10 20 30 35 40 45 50 55 60 70 90 µg/well
95.72 121.76 87.89 79.57 53.21 62.47 48.69 36.34 30.88 33.02 20.43 5.46 0.56
109.98 105.88 77.67 69.83 51.78 44.42 39.19 42.52 37.05 34.20 23.99 3.56 0.28
101.19 107.06 85.75 79.57 47.03 47.51 34.20 42.52 36.82 27.55 27.08 4.28 -3.92
97.86 76.25 77.91 45.84 59.62 45.37 39.43 31.35 22.80 22.57 4.04 -1.12
95.01 77.67 76.01 53.21 38.48 33.97 27.08 20.43 17.58 8.31 3.80 1.68
99.52 99.52 64.37 43.94 36.58 38.95 22.57 19.00 10.45 14.25 3.09 -1.68
116.47 79.10 69.12 56.77 43.47 30.88 38.72 30.40 17.81 14.25 8.55 19.33














21.00 3.00 11.00 7.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 8.00 number
99.94 111.57 92.49 73.77 50.98 45.69 38.06 34.53 28.95 22.57 17.84 4.66 2.42 Average
1.88 5.11 4.59 2.26 1.70 3.73 2.22 2.76 2.40 2.97 2.33 0.61 2.56 SE
8.63 8.85 15.22 5.99 4.80 10.56 6.27 7.81 6.78 8.40 6.59 1.72 7.24 SD







 Table 43. Statistical analysis (one way ANOVA) of the CHO cell cytotoxicity data of Dover Maylube E112.  
 
Data source: Data 22 in MWF 060908.SNB 
Group Name  N Missing Mean Std Dev SEM 
MLE112 0 µg/mL 20 0 99.892 8.852 1.979 
MLE112 10 µg/mL 3 0 111.569 8.850 5.109 
MLE112 50 µg/mL 11 0 92.489 15.222 4.589 
MLE112 100 µg/mL 7 0 73.770 5.985 2.262 
MLE112 150 µg/mL 8 0 50.980 4.801 1.697 
MLE112 175 µg/mL 8 0 45.695 10.563 3.735 
MLE112 200 µg/mL 8 0 38.064 6.266 2.215 
MLE112 225 µg/mL 8 0 34.531 7.807 2.760 
MLE112 250 µg/mL 8 0 28.949 6.779 2.397 
MLE112 275 µg/mL 8 0 22.565 8.398 2.969 
MLE112 300 µg/mL 8 0 17.844 6.593 2.331 
MLE112 350 µg/mL 8 0 4.662 1.722 0.609 
MLE112 450 µg/mL 8 0 2.416 7.243 2.561 
 
Source of Variation DF SS MS F P 
Between Groups 12 140284.084 11690.340 159.512 <0.001 
Residual 100 7328.813 73.288   
Total 112 147612.897    
 
The differences in the mean values among the treatment groups are greater than would be expected by chance; there 
is a statistically significant difference (P = <0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
Multiple Comparisons versus Control Group (Holm-Sidak method): Overall significance level = 0.05 
 
Comparisons for factor:  





MLE112 0 µg/mL vs. MLE112 400 µg/mL 97.476 27.218 4.921E-048 0.004 Yes 
MLE112 0 µg/mL vs. MLE112 350 µg/mL 95.231 26.591 3.824E-047 0.005 Yes 
MLE112 0 µg/mL vs. MLE112 300 µg/mL 82.048 22.910 1.406E-041 0.005 Yes 
MLE112 0 µg/mL vs. MLE112 275 µg/mL  77.327 21.592 1.963E-039 0.006 Yes 
MLE112 0 µg/mL vs. MLE112 250 µg/mL 70.943 19.810 2.149E-036 0.006 Yes 
MLE112 0 µg/mL vs. MLE112 225 µg/mL 65.361 18.251 1.341E-033 0.007 Yes 
MLE112 0 µg/mL vs. MLE112 200 µg/mL 61.828 17.264 9.225E-032 0.009 Yes 
MLE112 0 µg/mL vs. MLE112 175 µg/mL 54.197 15.134 1.307E-027 0.010 Yes 
MLE112 0 µg/mL vs. MLE112 150 µg/mL 48.912 13.658 1.357E-024 0.013 Yes 
MLE112 0 µg/mL vs. MLE112 100 µg/mL 26.122 6.948 03.82 E-11 0.017 Yes 
MLE112 0 µg/mL vs. MLE112 50 µg/mL 7.403 2.304 0.0233 0.025 Yes 
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 Dover Klorfree 100 
 
The summary data for the CHO cell cytotoxicity assay for the MWF component Dover Klorfree 
100 is presented in Table 44. As is indicated in the table, Dover Klorfree 100 does not exhibit 
cytotoxic activity (Figure 25). This is the only MWF or MWF component that we have assayed 
that demonstrates no cytotoxic response. We speculate that this lack of response is due to the 
insolubility of Dover Klorfree 100 in the DMSO/methanol stock solution and that this agent does 
not go into solution in the dilution series with the F12 cell medium (Figure 26). Thus, if Dover 




Table 44. Summary of CHO cell cytotoxicity of Dover Klorfree 100.  
























0 1 10 50 100 150 200 300 350 400 450 500 550 600 650 700 750 800 900 µg/ml
105.68 134.47 129.55 139.77 146.59 145.08 132.20 112.50 114.02 101.14 117.24 75.00 127.59 149.57 143.97 127.59 145.69 156.90 131.03
94.70 146.59 117.80 133.71 134.09 134.47 132.95 109.47 116.67 123.11 117.24 90.91 133.19 130.60 141.81 145.69 133.19 144.83 127.59
88.64 145.08 131.44 127.27 153.79 135.98 143.18 131.06 147.35 113.64 121.12 106.82 128.45 143.53 134.05 142.24 125.43 130.60 128.88
95.08 140.53 131.44 144.32 131.82 130.30 109.85 109.09 103.03 123.86 130.60 115.09 135.34 150.86 134.05 131.90 138.79 137.07 124.14
96.59 121.55 100.86 134.91 127.59 141.38 132.76 120.26 131.03 130.60 122.84
93.94 126.72 112.93 130.60 127.16 152.16 156.03 145.26 143.53 151.29 120.69
117.42 113.36 120.69 120.69 158.62 165.09 164.22 166.38 144.83 151.72 163.79









16 4 4 4 4 4 4 4 4 12 8 11 8 8 8 8 8 8 8 number
99.89 141.67 127.56 136.27 141.57 136.46 129.55 115.53 120.27 118.29 117.51 117.19 131.95 146.88 143.00 143.05 140.57 142.40 133.08 Average
2.50 2.72 3.28 3.70 5.21 3.11 7.03 5.23 9.50 2.69 2.98 6.33 4.23 3.57 4.06 5.86 3.99 3.60 5.16 SE
10.01 5.45 6.56 7.41 10.42 6.23 14.05 10.47 19.00 9.31 8.42 21.01 11.96 10.10 11.48 16.58 11.30 10.19 14.60 SD













































Figure 26. Photograph of 10% Dover Klorfree 100 sample in a DMSO: methanol solution. 
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A comparison of the CHO cell cytotoxicity data for the 12 MWF agents plus the 10 MWF 
components analyzed thus far is presented in Table 45. The lowest toxic response value is the 
concentration of the agent that induced a significant reduction in the cell density as compared to 
the negative control. After regression analysis the coefficient of determination (R2) was 
determined and the %C½ value for each concentration-response curve was calculated. The %C½ 
value (analogous to a LC50 value) is the concentration of the test agent that induced a cell density 
of 50% as compared to the concurrent negative control. A lower %C½ value denotes greater 
cytotoxicity. 
 
For the MWFs presented in Table 45, the rank order based on their descending cytotoxicity 
(based on the %C½ value) is Castrol 6510 > Castrol Clearedge 6536 > Alusol AU39 > Cimperial 
1070 > Vita Edge > Castrol 6519 > TrimSol > TrimE 20bnd > Eaton Hocut 763 > Hangsterfer’s 
S506 > Syntilo 9904 > IRMCO Cutting Fluid Product A. For the MWF components the rank 
order based on their descending cytotoxicity (based on the %C½ value) is Actramide 202 > 
Alkaterg T-IV > Busan 77 > Dover Mayfree 133 > Dover Maylube E112 > AMP95 > UCON 
EMPL-48 > Dover Sulperm HO > UCON 50-HB-6. Dover Klorfree 100 was insoluble under 




Table 45. Summary of the CHO cell cytotoxicity response by the MWF agents and components analyzed for 
this project. 
 
 MWF or Component Lowest Toxic Response (µg/mL) 
%C½ value 
(µg/mL) R




Castrol 6519 2.5 54.8 0.96 F12, 183 = 98.3; P ≤ 0.001 6 
Cimperial 1070 2.5 41.2 0.99 F15, 206 = 162.7; P ≤ 0.001 4 
Hangsterfer’s S506 35.0 128.5 0.87 F16, 234 = 162.7; P ≤ 0.001 10 
TrimE 20bnd 25.0 75.3 0.98 F11, 212 = 104.6; P ≤ 0.001 8 
TrimSol 35.0 73.2 0.99 F10, 163 = 107.9; P ≤ 0.001 7 
Castrol 6510 25.0 28.8 0.98 F8, 151 = 37.6; P ≤ 0.001 1 
Eaton Hocut 763 50.0 105.9 0.99 F8, 143 = 71.5; P ≤ 0.001 9 
Syntilo 9904 25.0 215.5 0.87 F20, 202 = 61.2; P ≤ 0.001 11 
Vita Edge 10.0 46.1 0.95 F10, 208 = 94.1; P ≤ 0.001 5 
Alusol AU39 5.0 32.0 0.98 F13, 162 = 255.3; P ≤ 0.001 3 
Castrol Clearedge 6536 5.0 30.2 0.88 F10, 173 = 130.2; P ≤ 0.001 2 







Busan 77 5.0 25.1 0.97 F8, 155 = 42.8; P ≤ 0.001 3 
UCON EMPL-48 125.0 261.3 0.96 F14, 237 = 20.1; P ≤ 0.001 7 
AMP95 125.0 171.0 0.97 F9, 147 = 21.3; P ≤ 0.001 6 
UCON 50-HB-6 200.0 429.2 0.89 F14, 151 = 19.0; P ≤ 0.001 9 
Alkaterg T-IV 5.0 14.1 0.98 F8, 98 = 170.9; P ≤ 0.001 2 
Actramide 202 8.0 10.1 0.95 F10, 111 = 48.2; P ≤ 0.001 1 
Dover Mayfree 133 25.0 32.3 0.97 F23, 14 = 105.4; P ≤ 0.001 4 
Dover Sulperm HO 350 428.6 0.96 F23, 19 = 54.4; P ≤ 0.001 8 
Dover Maylube E112 50 164.9 0.99 F12, 100 = 159.5; P ≤ 0.001 5 






 Table 46 presents the CHO cell cytotoxicity of U.S. EPA-regulated compounds. Figure 27 
illustrates a comparison of the mammalian cell cytotoxicity of these agents with the MWFs from 
the present study. The comparison illustrated in Figure 27 indicates that the cytotoxicity of 
MWFs is similar to agents that are regulated by the U.S. EPA (black bars). In general there is an 
overall cytotoxicity rank order of MWFs (from most toxic to less toxic) of semi-synthetic > 
soluble oil > synthetic (Figure 28). This is an important discovery and is supported by an in vivo 
study of guinea pigs exposed to MWFs [15]. The CHO cell cytotoxicity data generated in this 





Table 46. CHO cell cytotoxicity of selected U.S. EPA-regulated toxic agents. 
 
Trade Name Chemical Name Type of Agent %C½ Value (µg/mL) Reference 
2AAAF 
2-Acetoxyacetylamino-fluorene Arylamine  











herbicide 45.3 [35] 
2,4-D 
(2,4-dichlorophenoxy) acetic acid Phenoxy 








































Figure 27. Comparison of the mammalian cell chronic cytotoxicity of the 12 metalworking fluids analyzed in 
this study. The red bars represent semi-synthetic MWFs, the gray bars represent soluble oil MWFs, and the green 




Table 47 compares the impact of various classes of MWFs and their average %C½ values from 
the CHO cell cytotoxicity assays with the release of LDH protein, overall protein and PMN as 
measures of pulmonary distress in guinea pigs exposed to MWFs [15]. The correlation responses 
are negative due to the fact that lower %C½ values indicate higher cytotoxicity (Table 45, Figure 
27). Table 47 demonstrates that the in vitro CHO cell cytotoxicity assay is highly correlated to in 
vivo pulmonary toxicity measurements in animal models. This information suggests that the in 
vitro CHO cell cytotoxicity assay demonstrates a good level of confidence in predicting in vivo 
adverse health responses.  































































Soluble oil MWF 
Synthetic MWF 
EPA Regulated compounds 
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 Table 47. Correlation analyses among in vitro and in vivo measurements of MWF toxicity. 
 







Semi-synthetic 36.4 94.8 851.5 7.0 
Soluble Oils 76.6 87.5 691.9 2.3 
Synthetic 239.0 69.1 247.0 0.3 
Pearson Product Moment Correlation 
Coefficient between %C½ values (present 
study) and in vivo toxicity measurements [15] 




To further analyze the cytotoxicity of the three classes of MWFs, we generated CHO cell 
cytotoxicity index values. The mean %C½ value for the MWFs was calculated for each MWF 
class (synthetic, soluble oil and semi-synthetic) based on mg/L concentrations. The reciprocal of 
each mean was calculated so that a larger value corresponded with increasing cytotoxicity. These 
cytotoxicity index values are useful in that we can quantitatively compare the relative CHO cell 
cytotoxicity amongst these three MWF classes. The data in Figure 28 clearly indicate that the 
soluble oil and semi-synthetic classes of MWFs were 3.2 × and 6.5 × more cytotoxic than the 
synthetic MWFs. 
 
For the MWF components, the rank order based on their descending cytotoxicity (based on the 
%C½ value) is Actramide 202 > Alkaterg T-IV > Busan 77 > Dover Mayfree 133 > Dover 
Maylube E112 > AMP95 > UCON EMPL-48 > Dover Sulperm HO > UCON 50-HB-6. Dover 
Klorfree 100 was insoluble under conditions of the assay and thus could not be adequately 
analyzed. A comparison of the cytotoxicity of MWF components with known positive toxic 
agents and U.S. EPA-regulated compounds is presented in Figure 29. It is interesting to note that 
some of the components (Actramide 202, Alkaterg T-IV and Busan77) are more cytotoxic than 
the most cytotoxic MWF (Castrol 6510), and some components (Dover Sulperm HO and UCON 
50-HB-6) are less cytotoxic than the least potent MWF (IRMCO Cutting Fluid Product A). This 
broad range of response indicates the possibility to employ specific MWF components to 















































Figure 28. Comparison of the relative CHO cell cytotoxicity for the three metalworking fluids classes 









































































































































Figure 29. Comparison of the mammalian cell chronic cytotoxicity of the metalworking fluids components 









From this research project the following may be concluded. 
 
1. Twelve metal working fluids (MWFs) and ten metal working fluid components were 
evaluated for their chronic cytotoxicity using an in vitro CHO cell bioassay. 
2. For both the MWFs and the MWF components, the range of cytotoxicity was within 
standard toxic agents regulated by the U.S. Environmental Protection Agency. 
3. The MWF rank order, from most cytotoxic to least cytotoxic, was Castrol 6510 > Castrol 
Clearedge 6536 > Alusol AU39 > Cimperial 1070 > Vita Edge > Castrol 6519 > TrimSol 
> TrimE 20bnd > Eaton Hocut 763 > Hangsterfer’s S506 > Syntilo 9904 > IRMCO 
Cutting Fluid Product A. 
4. For the MWF classes, there is an overall descending cytotoxicity rank order of semi-
synthetic > soluble oil > synthetic. 
5. For these MWF classes, the CHO cell cytotoxicity assay was highly correlated to in vivo 
pulmonary toxicity measurements in animal models. 
6. The MWF component rank order, from most cytotoxic to least cytotoxic, was Atramide 
202 > Alkaterg T-IV > Busan 77 > Dover Mayfree 133 > Dover Maylube E112 > 
AMP95 > UCON EMPL-48 > Dover Sulperm HO > UCON 50-HB-6. Dover Klorfree 
100 could not be analyzed. 
7. For both the MWF and MWF components, a wide diversity of cytotoxicity is present. 
These data may be useful in selecting MWFs or MWF components that meet industry 
requirements and pose the lowest level of toxic hazard. 
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